Peptide COA Testing & Verification
Last updated Oct 8, 2026
890 lab certificates of analysis (COAs), searchable by lot number. Each lot page shows HPLC purity, identity result, test date and lab, plus a button that opens the lab's own verification record.
Affiliate disclosure: We earn a commission if you buy through the vendor links on this page, at no extra cost to you. Peptides & Coffee is an independent COA reference and is not owned by or affiliated with the vendors or labs listed. Lab results are published by the vendors and labs; we link to each lab's own verification record so you can check them yourself.
1. Find your lotThe lot or batch number is printed on the vial label. Type it in the search box below.
2. Open the lot pageSee the lab, test date, HPLC purity, identity result and the original COA document.
3. Verify at the labClick through to the lab's own record (Accumark Labs, Freedom Diagnostics, Janoshik) and check the numbers match.
Search COAs by lot, product or lab
| Lot | Product | Vendor | Test date | Lab | HPLC purity | Identity | Verify |
|---|---|---|---|---|---|---|---|
| MBLUE20-001T | Methylene Blue Tablets 20 mg 60ct Most recent | Peptira | 2026-09-26 | Freedom Diagnostics | Not reported | Confirmed (Blue) | Lab record ↗ |
| SLUPP100-001T | SLU-PP-332 Tablets 100 mg 60ct Most recent | Peptira | 2026-09-26 | Freedom Diagnostics | Not reported | Confirmed (Sample 2: SLU-PP-332) | Lab record ↗ |
| 10KWLV09082026 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Most recent | Paramount Peptides | 2026-09-22 | Accumark Labs | 99.62% | Conforms | Lab record ↗ |
| 5AM50-001T | 5-Amino 1MQ Tablets 50 mg 60ct Most recent | Peptira | 2026-09-19 | Freedom Diagnostics | Not reported | Confirmed (Sample 2: 5-Amino 1MQ) | Lab record ↗ |
| BPC.5-001T | BPC-157 Tablets 0.5 mg 60ct Most recent | Peptira | 2026-09-19 | Freedom Diagnostics | Not reported | Confirmed (Sample 2: BPC-157) | Lab record ↗ |
| EPIT3-001T | Epitalon Tablets 3 mg 60ct Most recent | Peptira | 2026-09-19 | Freedom Diagnostics | Not reported | Confirmed (Sample 2: Epitalon) | Lab record ↗ |
| GHK2-001T | GHK-Cu Tablets 2 mg 60ct Most recent | Peptira | 2026-09-19 | Freedom Diagnostics | Not reported | Confirmed (Sample 2: GHK-Cu) | Lab record ↗ |
| KPV.5-001T | KPV Tablets 0.5 mg 60ct Most recent | Peptira | 2026-09-19 | Freedom Diagnostics | Not reported | Confirmed (Sample 2: KPV) | Lab record ↗ |
| PINE3-001T | Pinealon Tablets 3 mg 60ct Most recent | Peptira | 2026-09-19 | Freedom Diagnostics | Not reported | Confirmed (Sample 2: Pinealon) | Lab record ↗ |
| ARA290-001 | ARA-290 Vial 30 mg Most recent | Peptira | 2026-09-14 | Freedom Diagnostics | 99.84% | Confirmed | Lab record ↗ |
| HSN-002A | HSN BLEND Liquid 20 ml Most recent | Peptira | 2026-09-05 | Freedom Diagnostics | Not reported | Mass identified as Vial 2: Choline/Niacinamide/Niacin/Pantot | Lab record ↗ |
| ADMX10-002 | Adamax Vial 10 mg Most recent | Peptira | 2026-08-29 | Freedom Diagnostics | 99.73% | Confirmed | Lab record ↗ |
| RETA30-015 | RETA-3 Vial 30 mg Most recent | Peptira | 2026-08-29 | Freedom Diagnostics | 99.87% | Confirmed | Lab record ↗ |
| RETA30-014 | RETA-3 Vial 30 mg Older lot | Peptira | 2026-08-29 | Freedom Diagnostics | 99.86% | Confirmed | Lab record ↗ |
| CARTA20-002 (8X) | Cartalax Vial 20 mg Most recent | Peptira | 2026-08-22 | Freedom Diagnostics | 99.85% | Confirmed | Lab record ↗ |
| LIPOCXL-002A (8X) | Lipo-C XL Liquid 20 ml Most recent | Peptira | 2026-08-22 | Freedom Diagnostics | Not reported | Mass identified as Vial 2: Choline/Carnitine/Arginine/Methio | Lab record ↗ |
| PE-22-10-002 | PE-22-28 Vial 10 mg Most recent | Peptira | 2026-08-22 | Freedom Diagnostics | 99.73% | Confirmed | Lab record ↗ |
| TESA10-012 | TESAMORELIN Vial 10 mg Most recent | Peptira | 2026-08-22 | Freedom Diagnostics | 99.85% | Confirmed | Lab record ↗ |
| TESA30-001 | TESAMORELIN Vial 30 mg Most recent | Peptira | 2026-08-22 | Freedom Diagnostics | 99.88% | Confirmed | Lab record ↗ |
| 15K2XIT04152026 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Most recent | Paramount Peptides | 2026-08-21 | Accumark Labs | 99.72% | Conforms | Lab record ↗ |
| DSP10N102725 | DSIP (10mg) Most recent | Paramount Peptides | 2026-08-21 | Accumark Labs | 99.23% | Conforms | Lab record ↗ |
| GLO70N071226 | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Most recent | Paramount Peptides | 2026-08-21 | Accumark Labs | 99.79% | Conforms | Lab record ↗ |
| IPA12012025-J | Ipamorelin (10mg) Most recent | Paramount Peptides | 2026-08-21 | Accumark Labs | 99.67% | Conforms | Lab record ↗ |
| TR12N040226 | Triple Regulator (TIA-39-C20) (12mg) Most recent | Paramount Peptides | 2026-08-21 | Accumark Labs | 99.78% | Conforms | Lab record ↗ |
| 10K2XCI5507242026 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Most recent | Paramount Peptides | 2026-08-12 | Accumark Labs | 99.85% | Conforms | Lab record ↗ |
| 22623 | Epithalon (50mg) Most recent | Paramount Peptides | 2026-08-11 | Accumark Labs | 99.90% | Conforms | Lab record ↗ |
| TA1-10-003 (8X) | THYMOSIN ALPHA-1 Vial 10 mg Most recent | Peptira | 2026-08-11 | Freedom Diagnostics | 99.69% | Confirmed | Lab record ↗ |
| KPV10-010 (8X) | KPV Vial 10 mg Most recent | Peptira | 2026-08-06 | Freedom Diagnostics | 99.82% | Confirmed | Lab record ↗ |
| RETA30-013 (8X) | RETA-3 Vial 30 mg Older lot | Peptira | 2026-08-06 | Freedom Diagnostics | 99.91% | Confirmed | Lab record ↗ |
| DR100N052226 | GLP-2 T - 100mg Most recent | Paramount Peptides | 2026-08-04 | Accumark Labs | 99.77% | Conforms | Lab record ↗ |
| BPC10-012 (8X) | BPC-157 Vial 10 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.69% | Confirmed | Lab record ↗ |
| EPIT10-005 (8X) | Epitalon Vial 10 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.77% | Confirmed | Lab record ↗ |
| GLUT1500-003 (8X) | Glutathione Vial 1500 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.84% | Confirmed | Lab record ↗ |
| RETA10-008 (8X) | RETA-3 Vial 10 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.95% | Confirmed | Lab record ↗ |
| RETA20-008 (8X) | RETA-3 Vial 20 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.95% | Confirmed | Lab record ↗ |
| SMAX10-008 (8X) | Semax Vial 10 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.68% | Confirmed | Lab record ↗ |
| WOLV10-009 (8X) | TB/BP Blend (Wolverine) Vial 10 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.06% | Confirmed | Lab record ↗ |
| TIRZ60-008 (8X) | TIRZ-2 Vial 60 mg Most recent | Peptira | 2026-08-04 | Freedom Diagnostics | 99.80% | Confirmed | Lab record ↗ |
| 4K2X10506082026 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2026-07-30 | Accumark Labs | 99.57% | Conforms | Lab record ↗ |
| CAG10-006 (8X) | CAG-4 Vial 10 mg Most recent | Peptira | 2026-07-28 | Freedom Diagnostics | 99.78% | Confirmed | Lab record ↗ |
| 26VCJC171 | CJC-1295 - No DAC (10mg) Most recent | Paramount Peptides | 2026-07-22 | Accumark Labs | 99.61% | Conforms | Lab record ↗ |
| 4KBPC2007052026 | BPC-157 (20mg) Most recent | Paramount Peptides | 2026-07-20 | Accumark Labs | 99.02% | Conforms | Lab record ↗ |
| 3K2X10206252026 | 2X Blend Tesamorelin (10mg) / Ipamorelin (2mg) Research Blend Most recent | Paramount Peptides | 2026-07-17 | Accumark Labs | 99.32% | Conforms | Lab record ↗ |
| 26VCJC170 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2026-07-17 | Accumark Labs | 99.49% | Conforms | Lab record ↗ |
| 26VTBC164 | Thymosin Beta 4 (TB500) (10mg) Most recent | Paramount Peptides | 2026-07-08 | Accumark Labs | 99.12% | Conforms | Lab record ↗ |
| 8K2XC04012026 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.47% | Conforms | Lab record ↗ |
| BPC10N062226 | BPC-157 (10mg) Most recent | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.44% | Conforms | Lab record ↗ |
| EPIT10102025-J | Epithalon (10mg) Most recent | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.07% | Conforms | Lab record ↗ |
| RET12#05582 | GLP-3 R - 12mg Most recent | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.69% | Conforms | Lab record ↗ |
| RET12#94068 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.90% | Conforms | Lab record ↗ |
| IPA10N081925 | Ipamorelin (10mg) Older lot | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.61% | Conforms | Lab record ↗ |
| OX102025 | Oxytocin (10mg) Most recent | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.03% | Conforms | Lab record ↗ |
| TBB20N060226 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-07-07 | Accumark Labs | 99.66% | Conforms | Lab record ↗ |
| BPC5N071725 | BPC-157 (5mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.63% | Conforms | Lab record ↗ |
| 26VCJC158 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.38% | Conforms | Lab record ↗ |
| DSIP10N102725 | DSIP (10mg) Older lot | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.02% | Conforms | Lab record ↗ |
| DSIP5N092225 | DSIP (5mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.09% | Conforms | Lab record ↗ |
| GHK100N061526 | GHK-Cu (100mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.98% | Conforms | Lab record ↗ |
| GLO50N061926 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.71% | Conforms | Lab record ↗ |
| IGF1A122925 | IGF-1 LR3 (1mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.09% | Conforms | Lab record ↗ |
| KLOW80N062226 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.79% | Conforms | Lab record ↗ |
| MEL209032025-J | MT-II (Melanotan II) (10mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.72% | Conforms | Lab record ↗ |
| SEL10N021226 | Selank (10mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.31% | Conforms | Lab record ↗ |
| SEL12142025-S | Selank (5mg) Most recent | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.66% | Conforms | Lab record ↗ |
| TB10-12222025-J | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2026-07-06 | Accumark Labs | 99.81% | Conforms | Lab record ↗ |
| CARTA20-001 | Cartalax Vial 20 mg Older lot | Peptira | 2026-07-03 | Freedom Diagnostics | 99.82% | Confirmed | Lab record ↗ |
| PEEL-002A | PEEL'd Liquid 20 ml Most recent | Peptira | 2026-07-03 | Freedom Diagnostics | Not reported | Confirmed (Vial 1: Methionine/Inositol/Choline/Carnitine Pyr | Lab record ↗ |
| SS50-005 | SS-31 Vial 50 mg Most recent | Peptira | 2026-07-03 | Freedom Diagnostics | 99.95% | Confirmed | Lab record ↗ |
| CDC10N061926 | CJC-1295 - With DAC (10mg) Most recent | Paramount Peptides | 2026-07-02 | Accumark Labs | 99.12% | Conforms | Lab record ↗ |
| KPV10N061626 | KPV (10mg) Most recent | Paramount Peptides | 2026-07-02 | Accumark Labs | 99.35% | Conforms | Lab record ↗ |
| DR10N060726 | GLP-2 T - 10mg Most recent | Paramount Peptides | 2026-07-01 | Accumark Labs | 99.99% | Conforms | Lab record ↗ |
| TR12N061026 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2026-07-01 | Accumark Labs | 99.96% | Conforms | Lab record ↗ |
| 4K2X10506062026 | 2X Blend Tesamorelin (10mg) / Ipamorelin (2mg) Research Blend Older lot | Paramount Peptides | 2026-06-30 | Accumark Labs | 99.57% | Conforms | Lab record ↗ |
| KLOW80N061226 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-06-30 | Accumark Labs | 99.60% | Conforms | Lab record ↗ |
| KPV10N061026 | KPV (10mg) Older lot | Paramount Peptides | 2026-06-30 | Accumark Labs | 99.35% | Conforms | Lab record ↗ |
| DR60N061026 | GLP-2 T - 60mg Most recent | Paramount Peptides | 2026-06-28 | Accumark Labs | 99.98% | Conforms | Lab record ↗ |
| TA10N060226 | Thymosin Alpha 1 (TA1) (10mg) Most recent | Paramount Peptides | 2026-06-28 | Accumark Labs | 99.56% | Conforms | Lab record ↗ |
| 15K2X10205252026 | 2X Blend Tesamorelin (10mg) / Ipamorelin (2mg) Research Blend Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.20% | Conforms | Lab record ↗ |
| 15K2X05262026 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.52% | Conforms | Lab record ↗ |
| 15K3X05272026 | 3X Blend Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Research Blend Most recent | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.17% | Conforms | Lab record ↗ |
| 26VBPC138 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.77% | Conforms | Lab record ↗ |
| CAG10N112925 | Cagrilintide (10mg) Most recent | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.75% | Conforms | Lab record ↗ |
| 26VCJC146 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.26% | Conforms | Lab record ↗ |
| EPI50#23116 | Epithalon (50mg) Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.12% | Conforms | Lab record ↗ |
| GHK50N061326 | GHK-Cu (50mg) Most recent | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.74% | Conforms | Lab record ↗ |
| GLO50N061226 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.77% | Conforms | Lab record ↗ |
| 36852 | MOTs-C (10mg) Most recent | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.68% | Conforms | Lab record ↗ |
| 36851 | MOTs-C (10mg) Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.69% | Conforms | Lab record ↗ |
| FNAD1000N052626 | NAD+ (1000mg) Most recent | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.94% | Conforms | Lab record ↗ |
| 83629 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2026-06-26 | Accumark Labs | 99.55% | Conforms | Lab record ↗ |
| EPIT50-062026-2 | Epithalon (50mg) Older lot | Paramount Peptides | 2026-06-25 | Accumark Labs | 99.55% | Conforms | Lab record ↗ |
| 4K2X10205302026 | 2X Blend Tesamorelin (10mg) / Ipamorelin (2mg) Research Blend Older lot | Paramount Peptides | 2026-06-23 | Accumark Labs | 99.41% | Conforms | Lab record ↗ |
| DR10N052526 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2026-06-23 | Accumark Labs | 99.96% | Conforms | Lab record ↗ |
| DR75N060326 | GLP-2 T - 75mg Most recent | Paramount Peptides | 2026-06-23 | Accumark Labs | 99.99% | Conforms | Lab record ↗ |
| MOT10N052926 | MOTs-C (10mg) Older lot | Paramount Peptides | 2026-06-23 | Accumark Labs | 99.32% | Conforms | Lab record ↗ |
| MOT10N051326 | MOTs-C (10mg) Older lot | Paramount Peptides | 2026-06-23 | Accumark Labs | 99.24% | Conforms | Lab record ↗ |
| MT210N053126 | MT-II (Melanotan II) (10mg) Older lot | Paramount Peptides | 2026-06-23 | Accumark Labs | 99.92% | Conforms | Lab record ↗ |
| TR60N053026 | GLP-3 R - 60mg Most recent | Paramount Peptides | 2026-06-18 | Accumark Labs | 99.75% | Conforms | Lab record ↗ |
| KPV10-009 | KPV Vial 10 mg Older lot | Peptira | 2026-06-18 | Freedom Diagnostics | 99.78% | Confirmed | Lab record ↗ |
| RETA20-007 | RETA-3 Vial 20 mg Older lot | Peptira | 2026-06-18 | Freedom Diagnostics | 99.89% | Confirmed | Lab record ↗ |
| RETA30-012 | RETA-3 Vial 30 mg Older lot | Peptira | 2026-06-18 | Freedom Diagnostics | 99.89% | Confirmed | Lab record ↗ |
| TESA10-011 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2026-06-18 | Freedom Diagnostics | 99.88% | Confirmed | Lab record ↗ |
| TBB20052726 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-06-16 | Accumark Labs | 99.69% | Conforms | Lab record ↗ |
| 5A1M-50-004 | 5-Amino 1MQ Vial 50 mg Most recent | Peptira | 2026-06-15 | Freedom Diagnostics | 99.70% | Confirmed | Lab record ↗ |
| AHK-001R | AHK-Cu Raw 1 g Most recent | Peptira | 2026-06-15 | Freedom Diagnostics | 99.95% | Confirmed | Lab record ↗ |
| MOTS10-009 | MOTS-C Vial 10 mg Most recent | Peptira | 2026-06-15 | Freedom Diagnostics | 99.75% | Confirmed | Lab record ↗ |
| NAD1000-003 | NAD+ Vial 1000 mg Most recent | Peptira | 2026-06-15 | Freedom Diagnostics | 99.96% | Confirmed | Lab record ↗ |
| CNI10N052326 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2026-06-09 | Accumark Labs | 99.35% | Conforms | Lab record ↗ |
| 26RU010 | GLP-2 T - 75mg Older lot | Paramount Peptides | 2026-06-09 | Accumark Labs | 99.96% | Conforms | Lab record ↗ |
| TR12N052126 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2026-06-09 | Accumark Labs | 99.59% | Conforms | Lab record ↗ |
| TBB20N052126 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-06-09 | Accumark Labs | 99.44% | Conforms | Lab record ↗ |
| BPTB20-052026-7 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-06-09 | Accumark Labs | 99.28% | Conforms | Lab record ↗ |
| 26VBPC031 | BPC-157 (5mg) Older lot | Paramount Peptides | 2026-06-04 | Accumark Labs | 99.97% | Conforms | Lab record ↗ |
| FNAD1000N051926 | NAD+ (1000mg) Biofermented (5ml Vial) Most recent | Paramount Peptides | 2026-06-04 | Accumark Labs | 99.97% | Conforms | Lab record ↗ |
| TBB20N051626 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-06-04 | Accumark Labs | 99.15% | Conforms | Lab record ↗ |
| SP-F002-52 | 5-Amino-1mq (50mg) x 60 Tablets Most recent | Paramount Peptides | 2026-06-02 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 26VBPC076 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-06-01 | Accumark Labs | 99.80% | Conforms | Lab record ↗ |
| 26VBPC136 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-06-01 | Accumark Labs | 99.89% | Conforms | Lab record ↗ |
| TES10N051626 | Tesamorelin (10mg) Most recent | Paramount Peptides | 2026-06-01 | Accumark Labs | 99.21% | Conforms | Lab record ↗ |
| 20KBPC2005052026 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-05-29 | Accumark Labs | 99.61% | Conforms | Lab record ↗ |
| DSIP10-052026-1 | DSIP (10mg) Older lot | Paramount Peptides | 2026-05-28 | Accumark Labs | 99.14% | Conforms | Lab record ↗ |
| TESM-032026-1 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2026-05-28 | Accumark Labs | 99.44% | Conforms | Lab record ↗ |
| BPTB20-032026-1 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-05-28 | Accumark Labs | 99.32% | Conforms | Lab record ↗ |
| BPC10-012 | BPC-157 Vial 10 mg Older lot | Peptira | 2026-05-28 | Freedom Diagnostics | 99.68% | Confirmed | Lab record ↗ |
| BPC10-011 | BPC-157 Vial 10 mg Older lot | Peptira | 2026-05-28 | Freedom Diagnostics | 99.13% | Confirmed | Lab record ↗ |
| CGEN20-001 | Cortagen Vial 20 mg Most recent | Peptira | 2026-05-28 | Freedom Diagnostics | 99.74% | Confirmed | Lab record ↗ |
| LIPOCXL-001 | Lipo-C XL Liquid 20 ml Older lot | Peptira | 2026-05-28 | Freedom Diagnostics | Not reported | Confirmed (L-Carnitine / L-Arginine / Dexpanthenol / Pyridox | Lab record ↗ |
| MOTS40-004 | MOTS-C Vial 40 mg Most recent | Peptira | 2026-05-28 | Freedom Diagnostics | 99.59% | Confirmed | Lab record ↗ |
| TGEN20-001 | Thymagen Vial 20 mg Most recent | Peptira | 2026-05-28 | Freedom Diagnostics | 99.48% | Confirmed | Lab record ↗ |
| SNAD1000N042026 | NAD+ (1000mg) Older lot | Paramount Peptides | 2026-05-18 | Accumark Labs | 99.73% | Conforms | Lab record ↗ |
| TBB10N051026 | Wolverine Blend - BPC-157 (5mg) / TB500 (5mg) Most recent | Paramount Peptides | 2026-05-18 | Accumark Labs | 99.24% | Conforms | Lab record ↗ |
| GLO50N042726 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-05-15 | Accumark Labs | 99.71% | Conforms | Lab record ↗ |
| 26VTBC110 | Thymosin Beta 4 (TB500) (20mg) Most recent | Paramount Peptides | 2026-05-15 | Accumark Labs | 99.39% | Conforms | Lab record ↗ |
| TBB10N050826 | Wolverine Blend - BPC-157 (5mg) / TB500 (5mg) Older lot | Paramount Peptides | 2026-05-15 | Accumark Labs | 99.26% | Conforms | Lab record ↗ |
| EPI10A121925 | Epithalon (10mg) Older lot | Paramount Peptides | 2026-05-14 | Accumark Labs | 96.58% | Conforms | Lab record ↗ |
| BPC20N042626 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-05-13 | Accumark Labs | 99.03% | Conforms | Lab record ↗ |
| 26VBPC115 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-05-13 | Accumark Labs | 99.46% | Conforms | Lab record ↗ |
| MOT10N042526 | MOTs-C (10mg) Older lot | Paramount Peptides | 2026-05-09 | Accumark Labs | 99.83% | Conforms | Lab record ↗ |
| GLO70N042426 | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-05-07 | Accumark Labs | 99.41% | Conforms | Lab record ↗ |
| TR60N042126 | GLP-3 R - 60mg Older lot | Paramount Peptides | 2026-05-07 | Accumark Labs | 99.65% | Conforms | Lab record ↗ |
| KLOW80N042526 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-05-07 | Accumark Labs | 99.38% | Conforms | Lab record ↗ |
| 26VTBL068 | Thymosin Beta 4 (TB500) (20mg) Older lot | Paramount Peptides | 2026-05-07 | Accumark Labs | 99.62% | Conforms | Lab record ↗ |
| IPA10-004 | Ipamorelin Vial 10 mg Most recent | Peptira | 2026-05-01 | Freedom Diagnostics | 99.93% | Confirmed | Lab record ↗ |
| MT1-10-007 | Melanotan-1 Vial 10 mg Most recent | Peptira | 2026-05-01 | Freedom Diagnostics | 99.91% | Confirmed | Lab record ↗ |
| TESA10-010 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2026-05-01 | Freedom Diagnostics | 99.84% | Confirmed | Lab record ↗ |
| VIL20-001 | Vilon Vial 20 mg Most recent | Peptira | 2026-05-01 | Freedom Diagnostics | 99.13% | Confirmed | Lab record ↗ |
| FNAD1000N040726 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2026-04-27 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GLO70N040426 | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-04-24 | Janoshik | Not tested | Compound(s) identified (per COA; see results) | Lab record ↗ |
| TR12N032326 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2026-04-24 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| CTX25N030326 | Cartalax (25mg) Most recent | Paramount Peptides | 2026-04-22 | Janoshik | 99.04% | Not reported | Lab record ↗ |
| DR30N031826 | GLP-2 T - 30mg Most recent | Paramount Peptides | 2026-04-18 | Janoshik | 99.83% | Not reported | Lab record ↗ |
| AOD6N032626 | AOD 9604 (6mg) Most recent | Paramount Peptides | 2026-04-17 | Janoshik | 99.53% | Not reported | Lab record ↗ |
| BPC1X600426 | BPC-157 (1mg) x 60 Tablets Most recent | Paramount Peptides | 2026-04-17 | Janoshik | Not reported | Not reported | Lab record ↗ |
| FOX15N030826 | FOXO4-DRI (15mg) Most recent | Paramount Peptides | 2026-04-17 | Janoshik | 99.80% | Not reported | Lab record ↗ |
| GLO50N030226 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-04-17 | Janoshik | Not reported | Not reported | Lab record ↗ |
| PE210N031126 | PE-22-28 (10mg) Most recent | Paramount Peptides | 2026-04-17 | Janoshik | 99.62% | Not reported | Lab record ↗ |
| 26VTBLO68 | Thymosin Beta 4 (TB500) (20mg) Older lot | Paramount Peptides | 2026-04-17 | Janoshik | 99.46% | Not reported | Lab record ↗ |
| TB45N030126 | Thymosin Beta 4 (TB500) (5mg) Most recent | Paramount Peptides | 2026-04-17 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| AOD6N031626 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2026-04-16 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| 2K4X1T04022026 | GHRP-2 (5mg) Most recent | Paramount Peptides | 2026-04-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GON5N032826 | Gonadorelin (5mg) Most recent | Paramount Peptides | 2026-04-16 | Janoshik | 99.89% | Not reported | Lab record ↗ |
| KLOW80N032526 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-04-16 | Janoshik | Not tested | Not reported | Lab record ↗ |
| MOT10-032026-1 | MOTs-C (10mg) Older lot | Paramount Peptides | 2026-04-16 | Janoshik | 99.64% | Not reported | Lab record ↗ |
| SNAD1000N032026 | NAD+ (1000mg) Synthetic (6ml Vial) Most recent | Paramount Peptides | 2026-04-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SEL10N031926 | Selank (10mg) Older lot | Paramount Peptides | 2026-04-16 | Janoshik | 99.52% | Not reported | Lab record ↗ |
| SEL5N022626 | Selank (5mg) Older lot | Paramount Peptides | 2026-04-16 | Janoshik | 99.60% | Not reported | Lab record ↗ |
| SMX30N022726 | Semax (30mg) Most recent | Paramount Peptides | 2026-04-16 | Janoshik | 99.34% | Not reported | Lab record ↗ |
| IPA/CJC10-005 | IPA/CJC Blend Vial 10 mg Most recent | Peptira | 2026-04-16 | Freedom Diagnostics | 99.96% | Confirmed | Lab record ↗ |
| TB5-10-005 | TB-500 Vial 10 mg Most recent | Peptira | 2026-04-16 | Freedom Diagnostics | 99.25% | Confirmed | Lab record ↗ |
| BPC10N030626 | BPC-157 (10mg) Older lot | Paramount Peptides | 2026-04-15 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| 26VBPCO76 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-04-15 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| GLO50N031126 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-04-15 | Janoshik | Not tested | Compound(s) identified (per COA; see results) | Lab record ↗ |
| SMX30N030626 | Semax (30mg) Older lot | Paramount Peptides | 2026-04-15 | Janoshik | 99.36% | Not reported | Lab record ↗ |
| LCARN-500-002 | L-CARNITINE Liquid 10 ml Most recent Discontinued | Peptira | 2026-04-15 | Freedom Diagnostics | 99.11% | Confirmed | Lab record ↗ |
| TIRZ30-009 | TIRZ-2 Vial 30 mg Most recent | Peptira | 2026-04-15 | Freedom Diagnostics | 99.88% | Confirmed | Lab record ↗ |
| SR20N031726 | GLP-1 S - 20mg Most recent | Paramount Peptides | 2026-04-14 | Janoshik | 99.90% | Not reported | Lab record ↗ |
| TR24N031226 | GLP-3 R - 24mg Most recent | Paramount Peptides | 2026-04-14 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| TR24N031426 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2026-04-14 | Janoshik | 99.92% | Not reported | Lab record ↗ |
| AOD5-004 | AOD-9604 Vial 5 mg Most recent | Peptira | 2026-04-12 | Freedom Diagnostics | 99.78% | Mass identified as AOD-9604 | Lab record ↗ |
| BPC10-010 | BPC-157 Vial 10 mg Older lot | Peptira | 2026-04-12 | Freedom Diagnostics | 99.19% | Mass identified as BPC-157 | Lab record ↗ |
| MOTS10-008 | MOTS-C Vial 10 mg Older lot | Peptira | 2026-04-12 | Freedom Diagnostics | 99.29% | Mass identified as MOTS-C | Lab record ↗ |
| MOTS10-007 | MOTS-C Vial 10 mg Older lot | Peptira | 2026-04-12 | Freedom Diagnostics | 99.42% | Mass identified as MOTS-C | Lab record ↗ |
| SEMA10-006 | SEMA-1 Vial 10 mg Most recent | Peptira | 2026-04-12 | Freedom Diagnostics | 99.73% | Mass identified as GLP SM | Lab record ↗ |
| SS10-004 | SS-31 Vial 10 mg Most recent | Peptira | 2026-04-12 | Freedom Diagnostics | 99.96% | Mass identified as SS-31 | Lab record ↗ |
| WOLV10-007 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2026-04-12 | Freedom Diagnostics | 99.18% | Not reported | Lab record ↗ |
| WOLV10-008 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2026-04-12 | Freedom Diagnostics | 99.38% | Not reported | Lab record ↗ |
| TESA10-009 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2026-04-12 | Freedom Diagnostics | 99.17% | Mass identified as Tesamorelin | Lab record ↗ |
| BPC10-009 | BPC-157 Vial 10 mg Older lot | Peptira | 2026-04-02 | Freedom Diagnostics | 98.15% | Not reported | Lab record ↗ |
| KPV10-008 | KPV Vial 10 mg Older lot | Peptira | 2026-04-02 | Freedom Diagnostics | 99.21% | Not reported | Lab record ↗ |
| SNAP10-004 | Snap-8 Vial 10 mg Most recent | Peptira | 2026-04-02 | Freedom Diagnostics | 99.85% | Not reported | Lab record ↗ |
| SNAP10-003 | Snap-8 Vial 10 mg Older lot | Peptira | 2026-04-02 | Freedom Diagnostics | 99.81% | Not reported | Lab record ↗ |
| TESA10-008 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2026-04-02 | Freedom Diagnostics | 99.07% | Not reported | Lab record ↗ |
| TIRZ10-005 | TIRZ-2 Vial 10 mg Most recent | Peptira | 2026-04-02 | Freedom Diagnostics | 99.88% | Not reported | Lab record ↗ |
| TIRZ20-006 | TIRZ-2 Vial 20 mg Most recent | Peptira | 2026-04-02 | Freedom Diagnostics | 99.92% | Not reported | Lab record ↗ |
| TIRZ60-007 | TIRZ-2 Vial 60 mg Older lot | Peptira | 2026-04-02 | Freedom Diagnostics | 99.85% | Not reported | Lab record ↗ |
| TRIM10N022626 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2026-03-31 | Janoshik | 99.63% | Not reported | Lab record ↗ |
| BPC10-008 | BPC-157 Vial 10 mg Older lot | Peptira | 2026-03-19 | Freedom Diagnostics | 99.24% | Mass identified as BPC-157 | Lab record ↗ |
| HSN-001A | HSN BLEND Liquid 20 ml Older lot | Peptira | 2026-03-19 | Freedom Diagnostics | Not reported | Mass identified as B5)/Choline/Inositol/Niac | Lab record ↗ |
| IGF1-1-004 | IGF1-LR3 Vial 1 mg Most recent | Peptira | 2026-03-19 | Freedom Diagnostics | 99.25% | Mass identified as IGF-LR3 | Lab record ↗ |
| IGF1-1-003 | IGF1-LR3 Vial 1 mg Older lot | Peptira | 2026-03-19 | Freedom Diagnostics | 99.19% | Mass identified as IGF-LR3 | Lab record ↗ |
| MOTS10-006 | MOTS-C Vial 10 mg Older lot | Peptira | 2026-03-19 | Freedom Diagnostics | 99.47% | Mass identified as MOTS-C | Lab record ↗ |
| NAD500-008 | NAD+ Vial 500 mg Most recent | Peptira | 2026-03-19 | Freedom Diagnostics | 99.86% | Mass identified as NAD+ | Lab record ↗ |
| PEEL-001A | PEEL'd Liquid 20 ml Older lot | Peptira | 2026-03-19 | Freedom Diagnostics | Not reported | Mass identified as ne/Carnitine/Pyridoxine | Lab record ↗ |
| PUMP-001A | Pumptira Liquid 20 ml Most recent | Peptira | 2026-03-19 | Freedom Diagnostics | Not reported | Mass identified as ine/Citrulline/Methionine/ | Lab record ↗ |
| TESA10-007 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2026-03-19 | Freedom Diagnostics | 99.70% | Mass identified as Tesamorelin | Lab record ↗ |
| DSIP10-02112026-J | DSIP (10mg) Older lot | Paramount Peptides | 2026-03-18 | Janoshik | 99.19% | Not reported | Lab record ↗ |
| HEX5N022526 | Hexarelin (5mg) Most recent | Paramount Peptides | 2026-03-18 | Janoshik | 99.40% | Not reported | Lab record ↗ |
| SMX30N022826 | Semax (30mg) Older lot | Paramount Peptides | 2026-03-18 | Janoshik | 99.22% | Not reported | Lab record ↗ |
| MS10N022626 | SS-31 (14mg) Most recent | Paramount Peptides | 2026-03-18 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| MS10N022826 | SS-31 (14mg) Older lot | Paramount Peptides | 2026-03-18 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| TMA20-02182026-J | Thymalin (20mg) Most recent | Paramount Peptides | 2026-03-17 | Janoshik | 99.33% | Not reported | Lab record ↗ |
| 26VBPCO44 | BPC-157 (10mg) Older lot | Paramount Peptides | 2026-03-16 | Janoshik | 99.92% | Not reported | Lab record ↗ |
| CTX25N022526 | Cartalax (25mg) Older lot | Paramount Peptides | 2026-03-16 | Janoshik | 99.55% | Not reported | Lab record ↗ |
| 1KCURCO03022026 | Curcumin (600mg) Most recent | Paramount Peptides | 2026-03-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| IGF1A030526 | IGF-1 LR3 (1mg) Older lot | Paramount Peptides | 2026-03-16 | Janoshik | 99.17% | Not reported | Lab record ↗ |
| PMG5N022426 | PEG MGF (5mg) Most recent | Paramount Peptides | 2026-03-16 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| 4X13A030326 | 4X Blend GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Most recent | Paramount Peptides | 2026-03-13 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CNI10N022426 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2026-03-06 | Janoshik | Not reported | Not reported | Lab record ↗ |
| RENEW60N022426 | GLP-3 R - 60mg Older lot | Paramount Peptides | 2026-03-06 | Janoshik | 99.82% | Not reported | Lab record ↗ |
| HEX5N020626 | Hexarelin (5mg) Older lot | Paramount Peptides | 2026-03-06 | Janoshik | 99.72% | Not reported | Lab record ↗ |
| KIS10N021926 | Kisspeptin (10mg) Most recent | Paramount Peptides | 2026-03-06 | Janoshik | 99.44% | Not reported | Lab record ↗ |
| SMX30N022026 | Semax (30mg) Older lot | Paramount Peptides | 2026-03-06 | Janoshik | 99.72% | Not reported | Lab record ↗ |
| SLIM50N022026 | GLP-1 S - 50mg Most recent | Paramount Peptides | 2026-03-05 | Janoshik | 99.80% | Not reported | Lab record ↗ |
| RENEW24N021826 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2026-03-05 | Janoshik | 99.54% | Not reported | Lab record ↗ |
| FNAD1000N021526 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2026-03-05 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TBB20N021926 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-03-05 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BAM15-001C | BAM15 Caps 50 mg 60ct Most recent Discontinued | Peptira | 2026-03-05 | Freedom Diagnostics | Not reported | Mass identified as BAM-15 | Lab record ↗ |
| GHK100-006 | GHK-Cu Vial 100 mg Most recent | Peptira | 2026-03-05 | Freedom Diagnostics | 99.93% | Mass identified as GHK-CU | Lab record ↗ |
| GHK50-008 | GHK-Cu Vial 50 mg Most recent | Peptira | 2026-03-05 | Freedom Diagnostics | 99.26% | Mass identified as GHK-CU | Lab record ↗ |
| MOTS10-005 | MOTS-C Vial 10 mg Older lot | Peptira | 2026-03-05 | Freedom Diagnostics | 99.80% | Mass identified as MOTS-C | Lab record ↗ |
| TIRZ30-008 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2026-03-05 | Freedom Diagnostics | 99.70% | Mass identified as GLP TZ | Lab record ↗ |
| 5A1M-50-002C | 5-Amino 1MQ Caps 50 mg 60ct Most recent Discontinued | Peptira | 2026-03-03 | Freedom Diagnostics | Not reported | Mass identified as 5-Amino 1MQ | Lab record ↗ |
| 3X8A022026 | 3X Blend Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Research Blend Older lot | Paramount Peptides | 2026-02-27 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 26VBPC023 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-02-27 | Janoshik | 99.75% | Not reported | Lab record ↗ |
| EPI10N021726 | Epithalon (10mg) Older lot | Paramount Peptides | 2026-02-27 | Janoshik | 99.68% | Not reported | Lab record ↗ |
| FOX15N021426 | FOXO4-DRI (15mg) Older lot | Paramount Peptides | 2026-02-27 | Janoshik | 99.73% | Not reported | Lab record ↗ |
| RENEW12N021326 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2026-02-27 | Janoshik | 99.61% | Not reported | Lab record ↗ |
| RENEW12N021726 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2026-02-27 | Janoshik | 99.40% | Not reported | Lab record ↗ |
| RENEW24N021426 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2026-02-27 | Janoshik | 99.79% | Not reported | Lab record ↗ |
| KLOW80N021626 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-02-25 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CNI10N020926 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2026-02-24 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 4xN021126 | 4X Blend GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Older lot | Paramount Peptides | 2026-02-24 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TYG20N021126 | Thymagen (Thymogen) (20mg) Most recent | Paramount Peptides | 2026-02-24 | Janoshik | 99.57% | Not reported | Lab record ↗ |
| PMG5n021026 | PEG MGF (5mg) Older lot | Paramount Peptides | 2026-02-23 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| GHK1-001R | GHK-Cu Raw 1 g Most recent | Peptira | 2026-02-21 | Freedom Diagnostics | Not reported | Mass identified as GHK-Cu | Lab record ↗ |
| RETA30-011 | RETA-3 Vial 30 mg Older lot | Peptira | 2026-02-21 | Freedom Diagnostics | 99.92% | Mass identified as GLP RT | Lab record ↗ |
| 2X12N012726 | 2X Blend Tesamorelin (10mg) / Ipamorelin (2mg) Research Blend Older lot | Paramount Peptides | 2026-02-20 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 26VBPCO17 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-02-20 | Janoshik | 99.95% | Not reported | Lab record ↗ |
| CDC10N012926 | CJC-1295 - With DAC (10mg) Older lot | Paramount Peptides | 2026-02-20 | Janoshik | 79.92% | Not reported | Lab record ↗ |
| AOD6N020826Z | AOD 9604 (6mg) Older lot | Paramount Peptides | 2026-02-18 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| AOD6N020826 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2026-02-18 | Janoshik | 99.62% | Not reported | Lab record ↗ |
| 2X15N011725 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2026-02-13 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 26VBPCO04 | BPC-157 (20mg) Older lot | Paramount Peptides | 2026-02-13 | Janoshik | 99.83% | Not reported | Lab record ↗ |
| RENEW12N011526 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2026-02-13 | Janoshik | 99.63% | Not reported | Lab record ↗ |
| AOD6N012626 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2026-02-11 | Janoshik | 99.26% | Not reported | Lab record ↗ |
| 26A002 | Fenbendazole (200mg) x 30 Tablets Most recent | Paramount Peptides | 2026-02-11 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 2X15N012426 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2026-02-10 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 25M047 | ATX-304 (100mg) x 60 Tablets Most recent | Paramount Peptides | 2026-02-10 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TRIM75N012526 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2026-02-10 | Janoshik | 99.87% | Not reported | Lab record ↗ |
| ADMX10-001 | Adamax Vial 10 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.77% | Mass identified as Adamax | Lab record ↗ |
| AICAR50-001 | Aicar Vial 50 mg Most recent | Peptira | 2026-02-10 | Freedom Diagnostics | 99.92% | Mass identified as Aicar | Lab record ↗ |
| GLUT1500-003 | Glutathione Vial 1500 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.80% | Mass identified as Glutathione | Lab record ↗ |
| KISS10-003 | Kisspeptin Vial 10 mg Most recent | Peptira | 2026-02-10 | Freedom Diagnostics | 99.71% | Mass identified as Kisspeptin | Lab record ↗ |
| KLOW80-006 | KLOW Vial 80 mg Most recent | Peptira | 2026-02-10 | Freedom Diagnostics | 99.91% | Not reported | Lab record ↗ |
| KLOW80-005 | KLOW Vial 80 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.93% | Not reported | Lab record ↗ |
| MT1-10-006 | Melanotan-1 Vial 10 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.89% | Mass identified as Melanotan-I | Lab record ↗ |
| PE-22-10-001 | PE-22-28 Vial 10 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.47% | Mass identified as PE-22-28 | Lab record ↗ |
| RETA10-008 | RETA-3 Vial 10 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.95% | Mass identified as GLP RT | Lab record ↗ |
| RETA10-007 (NEW LABEL) | RETA-3 Vial 10 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.92% | Mass identified as GLP RT | Lab record ↗ |
| RETA20-006 | RETA-3 Vial 20 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.89% | Mass identified as GLP RT | Lab record ↗ |
| RETA20-005 | RETA-3 Vial 20 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.92% | Mass identified as GLP RT | Lab record ↗ |
| RETA30-010 | RETA-3 Vial 30 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.26% | Mass identified as GLP RT | Lab record ↗ |
| RETA30-009 | RETA-3 Vial 30 mg Older lot | Peptira | 2026-02-10 | Freedom Diagnostics | 99.93% | Mass identified as GLP RT | Lab record ↗ |
| TAML10-001 | Thymalin Vial 10 mg Most recent | Peptira | 2026-02-10 | Freedom Diagnostics | 99.71% | Mass identified as Thymalin | Lab record ↗ |
| RENEW12N012226 | GLP-3 R - 10mg Most recent | Paramount Peptides | 2026-02-09 | Janoshik | 99.62% | Not reported | Lab record ↗ |
| RENEW24N012326 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2026-02-09 | Janoshik | 99.54% | Not reported | Lab record ↗ |
| TES20N012026 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2026-02-09 | Janoshik | 99.58% | Not reported | Lab record ↗ |
| 26A001 | SLU-PP-332 (1mg) x 60 Tablets Most recent | Paramount Peptides | 2026-02-06 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TRIM 120N011726 | GLP-2 T - 120mg Most recent | Paramount Peptides | 2026-02-02 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| RENEW12N011826 | GLP-3 R - 10mg Older lot | Paramount Peptides | 2026-02-02 | Janoshik | 99.69% | Not reported | Lab record ↗ |
| PT110N011226 | PT-141 (10mg) Most recent | Paramount Peptides | 2026-02-02 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| ARA10-002 | ARA-290 Vial 10 mg Most recent | Peptira | 2026-01-31 | Freedom Diagnostics | 99.72% | Mass identified as ARA-290 | Lab record ↗ |
| CJCD5-004 | CJC-1295 DAC Vial 5 mg Most recent | Peptira | 2026-01-31 | Freedom Diagnostics | 99.77% | Mass identified as CJC-1295 with DAC | Lab record ↗ |
| GHK2-001C | GHK-Cu Caps 2 mg 60ct Most recent Discontinued | Peptira | 2026-01-31 | Freedom Diagnostics | Not reported | Mass identified as GHK-Cu | Lab record ↗ |
| LL37-5-002 | LL-37 Vial 5 mg Most recent | Peptira | 2026-01-31 | Freedom Diagnostics | 99.93% | Mass identified as LL-37 | Lab record ↗ |
| SLU500-001C | SLU-PP-332 Caps 500 mg 60ct Most recent Discontinued | Peptira | 2026-01-31 | Freedom Diagnostics | Not reported | Mass identified as SLU-PP-332 | Lab record ↗ |
| SLUBAM1-001C | SLU/BAM15 Caps 1 mg 60ct Most recent Discontinued | Peptira | 2026-01-31 | Freedom Diagnostics | Not reported | Mass identified as ee | Lab record ↗ |
| SURVO10-001 | Survo Vial 10 mg Most recent | Peptira | 2026-01-31 | Freedom Diagnostics | 99.87% | Mass identified as Survodutide | Lab record ↗ |
| CJCD5-003 | CJC-1295 DAC Vial 5 mg Older lot | Peptira | 2026-01-26 | Freedom Diagnostics | 99.71% | Mass identified as CJC-1295 with DAC | Lab record ↗ |
| GHK100-004 | GHK-Cu Vial 100 mg Older lot | Peptira | 2026-01-26 | Freedom Diagnostics | 99.70% | Mass identified as GHK-Cu | Lab record ↗ |
| RETA10-007 | RETA-3 Vial 10 mg Older lot | Peptira | 2026-01-26 | Freedom Diagnostics | 99.86% | Mass identified as GLP RT | Lab record ↗ |
| GLO50N121925 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-01-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| AOD5-003 | AOD-9604 Vial 5 mg Older lot | Peptira | 2026-01-18 | Freedom Diagnostics | 99.63% | Mass identified as AOD-9604 | Lab record ↗ |
| BADG1-001C | BPC/KPV Caps 1 mg 60ct Most recent Discontinued | Peptira | 2026-01-18 | Freedom Diagnostics | Not reported | Mass identified as BPC/KPV | Lab record ↗ |
| GHK50-007 | GHK-Cu Vial 50 mg Older lot | Peptira | 2026-01-18 | Freedom Diagnostics | 99.75% | Mass identified as GHK-Cu | Lab record ↗ |
| KISS10-002 | Kisspeptin Vial 10 mg Older lot | Peptira | 2026-01-18 | Freedom Diagnostics | 99.66% | Mass identified as Kisspeptin | Lab record ↗ |
| FNAD1000N122125 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2026-01-12 | Janoshik | Not reported | Not reported | Lab record ↗ |
| FNAD1000N121225 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2026-01-12 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GHK50-006 | GHK-Cu Vial 50 mg Older lot | Peptira | 2026-01-11 | Freedom Diagnostics | 99.83% | Mass identified as GHK-Cu | Lab record ↗ |
| GHRP6-5-001 | GHRP-6 Vial 5 mg Most recent | Peptira | 2026-01-11 | Freedom Diagnostics | 99.88% | Mass identified as GHRP-6 | Lab record ↗ |
| GLUT1500-002 | Glutathione Vial 1500 mg Older lot | Peptira | 2026-01-11 | Freedom Diagnostics | 99.20% | Mass identified as Glutathione | Lab record ↗ |
| KLOW80-004 | KLOW Vial 80 mg Older lot | Peptira | 2026-01-11 | Freedom Diagnostics | 99.76% | Not reported | Lab record ↗ |
| SEMA10-005 | SEMA-1 Vial 10 mg Older lot | Peptira | 2026-01-11 | Freedom Diagnostics | 99.86% | Mass identified as GLP SM | Lab record ↗ |
| SERM10-006 | Sermorelin Vial 10 mg Most recent | Peptira | 2026-01-11 | Freedom Diagnostics | 99.51% | Mass identified as Sermorelin | Lab record ↗ |
| WOLV10-006 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2026-01-11 | Freedom Diagnostics | 99.24% | Not reported | Lab record ↗ |
| TA1-5-002 | Thymosin Alpha 1 (Tα1) Vial 5 mg Most recent Discontinued | Peptira | 2026-01-11 | Freedom Diagnostics | 99.64% | Mass identified as Thymosin Alpha-1 | Lab record ↗ |
| TIRZ60-006 | TIRZ-2 Vial 60 mg Older lot | Peptira | 2026-01-11 | Freedom Diagnostics | 99.95% | Mass identified as GLP TZ | Lab record ↗ |
| CNI10N122325 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2026-01-09 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 2X12N121825 | 2X Blend Tesamorelin (10mg) / Ipamorelin (2mg) Research Blend Older lot | Paramount Peptides | 2026-01-09 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 3X8N121125 | 3X Blend Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Research Blend Older lot | Paramount Peptides | 2026-01-09 | Janoshik | Not reported | Not reported | Lab record ↗ |
| T120N122325 | GLP-2 T - 120mg Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| T30N121325 | GLP-2 T - 30mg Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.75% | Not reported | Lab record ↗ |
| T30N121525 | GLP-2 T - 30mg Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.82% | Not reported | Lab record ↗ |
| T60N122325 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.71% | Not reported | Lab record ↗ |
| R24N122225 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.08% | Not reported | Lab record ↗ |
| KLOW80N122025 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2026-01-09 | Janoshik | Not reported | Not reported | Lab record ↗ |
| KPV10N121325 | KPV (10mg) Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.53% | Not reported | Lab record ↗ |
| KPV10N121925 | KPV (10mg) Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.55% | Not reported | Lab record ↗ |
| TB410N121525 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2026-01-09 | Janoshik | 99.69% | Not reported | Lab record ↗ |
| T120N121825 | GLP-2 T - 120mg Older lot | Paramount Peptides | 2026-01-08 | Janoshik | 99.81% | Not reported | Lab record ↗ |
| T60N121725 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2026-01-08 | Janoshik | 99.71% | Not reported | Lab record ↗ |
| R24N121625 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2026-01-08 | Janoshik | 99.23% | Not reported | Lab record ↗ |
| PHX30-001 | KPV/TB/BPC (Phoenix) Vial 30 mg Most recent | Peptira | 2026-01-01 | Freedom Diagnostics | 99.68% | Not reported | Lab record ↗ |
| MT2-10-004 | Melanotan-2 Vial 10 mg Most recent | Peptira | 2026-01-01 | Freedom Diagnostics | 99.84% | Not reported | Lab record ↗ |
| OXY2-003 | Oxytocin Vial 2 mg Most recent | Peptira | 2026-01-01 | Freedom Diagnostics | 99.58% | Not reported | Lab record ↗ |
| PT10-004 | PT-141 Vial 10 mg Most recent | Peptira | 2026-01-01 | Freedom Diagnostics | 99.95% | Not reported | Lab record ↗ |
| SLNK10-004 | Selank Vial 10 mg Most recent | Peptira | 2026-01-01 | Freedom Diagnostics | 99.77% | Not reported | Lab record ↗ |
| SEMA20-005 | SEMA-1 Vial 20 mg Most recent | Peptira | 2026-01-01 | Freedom Diagnostics | 99.77% | Not reported | Lab record ↗ |
| SMAX10-007 | Semax Vial 10 mg Older lot | Peptira | 2026-01-01 | Freedom Diagnostics | 99.35% | Not reported | Lab record ↗ |
| TIRZ30-007 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2026-01-01 | Freedom Diagnostics | 99.57% | Not reported | Lab record ↗ |
| CNI10N120925 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-12-31 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GHK50-005 | GHK-Cu Vial 50 mg Older lot | Peptira | 2025-12-31 | Freedom Diagnostics | 99.61% | Mass identified as GHK-Cu | Lab record ↗ |
| RETA10-006 | RETA-3 Vial 10 mg Older lot | Peptira | 2025-12-31 | Freedom Diagnostics | 99.81% | Mass identified as GLP RT | Lab record ↗ |
| AOD6N121025 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-12-30 | Janoshik | 99.03% | Not reported | Lab record ↗ |
| GLO50N120625 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-12-30 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GLO70N121125 | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-12-30 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GON10A121325 | Gonadorelin (10mg) Most recent | Paramount Peptides | 2025-12-30 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| KLOW80N121425 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-12-30 | Janoshik | Not reported | Not reported | Lab record ↗ |
| FNAD1500N120925 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-12-30 | Janoshik | Not reported | Not reported | Lab record ↗ |
| PMG5N120925 | PEG MGF (5mg) Older lot | Paramount Peptides | 2025-12-30 | Janoshik | 99.72% | Not reported | Lab record ↗ |
| 5A1M-50-003 | 5-Amino 1MQ Vial 50 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.66% | Mass identified as 5-Amino 1MQ | Lab record ↗ |
| BPC10-007 | BPC-157 Vial 10 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.14% | Mass identified as BPC-157 | Lab record ↗ |
| BPC10-006 | BPC-157 Vial 10 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.27% | Mass identified as BPC-157 | Lab record ↗ |
| CJCND10-005 | CJC-1295 (NoDAC) Vial 10 mg Most recent | Peptira | 2025-12-26 | Freedom Diagnostics | 99.88% | Mass identified as CJC-1295 | Lab record ↗ |
| GHK100-005 | GHK-Cu Vial 100 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.37% | Mass identified as GHK-Cu | Lab record ↗ |
| LL37-5-001 | LL-37 Vial 5 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.79% | Mass identified as LL-37 | Lab record ↗ |
| NAD500-007 | NAD+ Vial 500 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.65% | Mass identified as NAD+ | Lab record ↗ |
| RETA10-005 | RETA-3 Vial 10 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.80% | Mass identified as GLP-RT | Lab record ↗ |
| SS50-004 | SS-31 Vial 50 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.96% | Mass identified as SS-31 | Lab record ↗ |
| WOLV10-005 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.05% | Mass identified as Appearance | Lab record ↗ |
| TESA10-006 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.03% | Mass identified as Tesamorelin | Lab record ↗ |
| TIRZ60-005 | TIRZ-2 Vial 60 mg Older lot | Peptira | 2025-12-26 | Freedom Diagnostics | 99.85% | Mass identified as GLP-TZ | Lab record ↗ |
| DSIP10-003 | DSIP Vial 10 mg Most recent | Peptira | 2025-12-23 | Freedom Diagnostics | 98.72% | Mass identified as DSIP | Lab record ↗ |
| EPIT10-004 | Epitalon Vial 10 mg Older lot | Peptira | 2025-12-23 | Freedom Diagnostics | 99.10% | Mass identified as Epithalon | Lab record ↗ |
| KPV10-007 | KPV Vial 10 mg Older lot | Peptira | 2025-12-23 | Freedom Diagnostics | 99.52% | Mass identified as KPV | Lab record ↗ |
| OXY2-002 | Oxytocin Vial 2 mg Older lot | Peptira | 2025-12-23 | Freedom Diagnostics | 99.52% | Mass identified as Oxytocin | Lab record ↗ |
| SMAX10-006 | Semax Vial 10 mg Older lot | Peptira | 2025-12-23 | Freedom Diagnostics | 99.30% | Mass identified as Semax | Lab record ↗ |
| SS50-003 | SS-31 Vial 50 mg Older lot | Peptira | 2025-12-23 | Freedom Diagnostics | 99.91% | Mass identified as SS-31 | Lab record ↗ |
| 2X+15N120125 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2025-12-18 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 25L041 | Orforglipron (12mg) x 60 Tablets Most recent | Paramount Peptides | 2025-12-18 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 25M045 | Orforglipron (12mg) x 60 Tablets Older lot | Paramount Peptides | 2025-12-18 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 25M044 | Orforglipron (6mg) x 60 Tablets Most recent | Paramount Peptides | 2025-12-18 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TB5-10-004 | TB-500 Vial 10 mg Older lot | Peptira | 2025-12-18 | Freedom Diagnostics | 99.30% | Mass identified as Thymosin Beta-4 | Lab record ↗ |
| WOLV10-004 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2025-12-18 | Freedom Diagnostics | 99.18% | Mass identified as Appearance | Lab record ↗ |
| GLO70N120225 | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-12-17 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TBB20N120325 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-12-17 | Janoshik | Not reported | Not reported | Lab record ↗ |
| ARA10-001 | ARA-290 Vial 10 mg Older lot | Peptira | 2025-12-15 | Freedom Diagnostics | 99.67% | Mass identified as ARA-290 | Lab record ↗ |
| KPV10-006 | KPV Vial 10 mg Older lot | Peptira | 2025-12-15 | Freedom Diagnostics | 99.61% | Mass identified as KPV | Lab record ↗ |
| TA1-5-001 | Thymosin Alpha 1 (Tα1) Vial 5 mg Older lot Discontinued | Peptira | 2025-12-15 | Freedom Diagnostics | 99.92% | Mass identified as Thymosin Alpha-1 | Lab record ↗ |
| GHK100-003 | GHK-Cu Vial 100 mg Older lot | Peptira | 2025-12-12 | Freedom Diagnostics | 99.86% | Mass identified as GHK-Cu | Lab record ↗ |
| GHK50-004 | GHK-Cu Vial 50 mg Older lot | Peptira | 2025-12-12 | Freedom Diagnostics | 99.99% | Mass identified as GHK-Cu | Lab record ↗ |
| NAD500-006 | NAD+ Vial 500 mg Older lot | Peptira | 2025-12-12 | Freedom Diagnostics | 99.87% | Mass identified as NAD+ | Lab record ↗ |
| TBB20N113025 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-12-11 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TES15N120125 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-12-10 | Janoshik | 99% | Not reported | Lab record ↗ |
| T60N112525 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-12-09 | Janoshik | 99.71% | Not reported | Lab record ↗ |
| FNAD1000F112125 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-12-09 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 5A1M-50-001C | 5-Amino 1MQ Caps 50 mg 60ct Older lot Discontinued | Peptira | 2025-12-06 | Freedom Diagnostics | Not reported | Mass identified as 5-Amino 1MQ | Lab record ↗ |
| BPC500-001C | BPC-157 Caps 500 mg 60ct Most recent Discontinued | Peptira | 2025-12-06 | Freedom Diagnostics | Not reported | Mass identified as BPC-157 | Lab record ↗ |
| GHK100-002 | GHK-Cu Vial 100 mg Older lot | Peptira | 2025-12-06 | Freedom Diagnostics | 99.02% | Mass identified as GHK-Cu | Lab record ↗ |
| GHK50-003 | GHK-Cu Vial 50 mg Older lot | Peptira | 2025-12-06 | Freedom Diagnostics | 99.03% | Mass identified as GHK-Cu | Lab record ↗ |
| GLW70-004 | GLOW Vial 70 mg Most recent | Peptira | 2025-12-06 | Freedom Diagnostics | 99.47% | Mass identified as Appearance | Lab record ↗ |
| MOTS40-003 | MOTS-C Vial 40 mg Older lot | Peptira | 2025-12-06 | Freedom Diagnostics | 99.75% | Mass identified as MOTS-C | Lab record ↗ |
| NAD1000-002 | NAD+ Vial 1000 mg Older lot | Peptira | 2025-12-06 | Freedom Diagnostics | 99.96% | Mass identified as NAD+ | Lab record ↗ |
| OXY2-001 | Oxytocin Vial 2 mg Older lot | Peptira | 2025-12-06 | Freedom Diagnostics | 99.06% | Mass identified as Oxytocin | Lab record ↗ |
| SERM10-005 | Sermorelin Vial 10 mg Older lot | Peptira | 2025-12-06 | Freedom Diagnostics | 99.20% | Mass identified as Sermorelin | Lab record ↗ |
| TESO500-001C | Tesofensine Caps 500 mg 60ct Most recent Discontinued | Peptira | 2025-12-06 | Freedom Diagnostics | Not reported | Mass identified as Tesofensine | Lab record ↗ |
| BP92025A | BPC-157 (5mg) Older lot | Paramount Peptides | 2025-12-05 | Janoshik | 99.49% | Not reported | Lab record ↗ |
| GLO50N112225 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-12-04 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TB92025 | Thymosin Beta 4 (TB500) (5mg) Older lot | Paramount Peptides | 2025-12-04 | Janoshik | 99.04% | Not reported | Lab record ↗ |
| 25L040 | 5-Amino-1mq (30mg) x 60 Tablets Most recent | Paramount Peptides | 2025-12-03 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 25L039 | Dihexa (10mg) x 30 Tablets Most recent | Paramount Peptides | 2025-12-03 | Janoshik | Not reported | Not reported | Lab record ↗ |
| R24N112225 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-12-03 | Janoshik | 99.65% | Not reported | Lab record ↗ |
| T100N112425 | GLP-2 T - 100mg Older lot | Paramount Peptides | 2025-12-02 | Janoshik | 99.86% | Not reported | Lab record ↗ |
| R24N111925 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-12-02 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| MC092025 | MOTs-C (10mg) Older lot | Paramount Peptides | 2025-12-02 | Janoshik | 99.31% | Not reported | Lab record ↗ |
| SER10N112025 | Sermorelin (10mg) Most recent | Paramount Peptides | 2025-12-02 | Janoshik | 99.09% | Not reported | Lab record ↗ |
| BDNF10A111725 | P21 / BDNF (Brain-derived neurotrophic factor) (10mg) Most recent | Paramount Peptides | 2025-11-29 | Janoshik | 99.28% | Not reported | Lab record ↗ |
| T40N111825 | GLP-2 T - 40mg Most recent | Paramount Peptides | 2025-11-28 | Janoshik | 99.88% | Not reported | Lab record ↗ |
| T60N111325 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-11-28 | Janoshik | 99.89% | Not reported | Lab record ↗ |
| TA82025 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2025-11-28 | Janoshik | 99.40% | Not reported | Lab record ↗ |
| TB420N111825 | Thymosin Beta 4 (TB500) (20mg) Older lot | Paramount Peptides | 2025-11-28 | Janoshik | 99.55% | Not reported | Lab record ↗ |
| AR102025 | ARA-290 (14mg) Most recent | Paramount Peptides | 2025-11-27 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| MOT10N111725 | MOTs-C (10mg) Older lot | Paramount Peptides | 2025-11-27 | Janoshik | 99.18% | Not reported | Lab record ↗ |
| SNAD1000N111025 | NAD+ (1000mg) Synthetic (6ml Vial) Older lot | Paramount Peptides | 2025-11-27 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TBB30N111925 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-11-27 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CAG10N111225 | Cagrilintide (10mg) Older lot | Paramount Peptides | 2025-11-25 | Janoshik | 99.56% | Not reported | Lab record ↗ |
| S10N111625 | GLP-1 S - 10mg Most recent | Paramount Peptides | 2025-11-25 | Janoshik | 99.63% | Not reported | Lab record ↗ |
| T75N111225 | GLP-2 T - 75mg Older lot | Paramount Peptides | 2025-11-25 | Janoshik | 99.69% | Not reported | Lab record ↗ |
| MT210N111225 | MT-II (Melanotan II) (10mg) Older lot | Paramount Peptides | 2025-11-25 | Janoshik | 99.50% | Not reported | Lab record ↗ |
| SNAD1000N111425 | NAD+ (1000mg) Synthetic (6ml Vial) Older lot | Paramount Peptides | 2025-11-25 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TBB20N111325 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-11-25 | Janoshik | Not reported | Not reported | Lab record ↗ |
| DSP5N111025 | DSIP (5mg) Older lot | Paramount Peptides | 2025-11-24 | Janoshik | 99.11% | Not reported | Lab record ↗ |
| T100N110925 | GLP-2 T - 100mg Older lot | Paramount Peptides | 2025-11-24 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| EPI10N111125 | Epithalon (10mg) Older lot | Paramount Peptides | 2025-11-21 | Janoshik | 99.03% | Not reported | Lab record ↗ |
| EPI50A111425 | Epithalon (50mg) Older lot | Paramount Peptides | 2025-11-21 | Janoshik | 99.45% | Not reported | Lab record ↗ |
| TES20N110525 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-11-21 | Janoshik | 99.18% | Not reported | Lab record ↗ |
| BPC10N110325 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.42% | Not reported | Lab record ↗ |
| CAG10N110525 | Cagrilintide (10mg) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.50% | Not reported | Lab record ↗ |
| CDC10N110325 | CJC-1295 - With DAC (10mg) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.01% | Not reported | Lab record ↗ |
| T40N110425 | GLP-2 T - 40mg Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| R60N110525 | GLP-3 R - 60mg Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.57% | Not reported | Lab record ↗ |
| FNAD1000N110325 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | Not reported | Not reported | Lab record ↗ |
| FNAD1000N110625 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TB410A110725 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.24% | Not reported | Lab record ↗ |
| TB45A110725 | Thymosin Beta 4 (TB500) (5mg) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.02% | Not reported | Lab record ↗ |
| TB45A110825 | Thymosin Beta 4 (TB500) (5mg) Older lot | Paramount Peptides | 2025-11-20 | Janoshik | 99.22% | Not reported | Lab record ↗ |
| 5A1M-50-002 | 5-Amino 1MQ Vial 50 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.62% | Mass identified as 5-Amino 1MQ | Lab record ↗ |
| CAG10-005 | CAG-4 Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.82% | Mass identified as Cagrilintide | Lab record ↗ |
| CJCND10-004 | CJC-1295 (NoDAC) Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.88% | Mass identified as CJC-1295 | Lab record ↗ |
| KLOW80-003 | KLOW Vial 80 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.66% | Mass identified as Appearance | Lab record ↗ |
| LCARN-500-001 | L-CARNITINE Liquid 20 ml Most recent | Peptira | 2025-11-20 | Freedom Diagnostics | 99.47% | Mass identified as Carnitine | Lab record ↗ |
| MT2-10-003 | Melanotan-2 Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.78% | Mass identified as Melanotan-II | Lab record ↗ |
| PINE10-001 | Pinealon Vial 10 mg Most recent Discontinued | Peptira | 2025-11-20 | Freedom Diagnostics | 99.59% | Mass identified as Pinealon | Lab record ↗ |
| PT10-003 | PT-141 Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.92% | Mass identified as PT-141 | Lab record ↗ |
| SLNK10-003 | Selank Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.75% | Mass identified as Selank | Lab record ↗ |
| SS10-003 | SS-31 Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.59% | Mass identified as SS-31 | Lab record ↗ |
| TB5-10-003 | TB-500 Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 99.44% | Mass identified as Thymosin Beta-4 | Lab record ↗ |
| TESA10-005 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2025-11-20 | Freedom Diagnostics | 98.65% | Mass identified as Tesamorelin | Lab record ↗ |
| VIP10-001 | VIP Vial 10 mg Most recent | Peptira | 2025-11-20 | Freedom Diagnostics | 99.23% | Mass identified as VIP | Lab record ↗ |
| $20N110725 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-11-19 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| BPC10-005 | BPC-157 Vial 10 mg Older lot | Peptira | 2025-11-13 | Freedom Diagnostics | 99.14% | Mass identified as BPC-157 | Lab record ↗ |
| IPA10-003 | Ipamorelin Vial 10 mg Older lot | Peptira | 2025-11-13 | Freedom Diagnostics | 99.79% | Mass identified as Ipamorelin | Lab record ↗ |
| NAD500-005 | NAD+ Vial 500 mg Older lot | Peptira | 2025-11-13 | Freedom Diagnostics | 99.98% | Mass identified as NAD+ | Lab record ↗ |
| T60N102925 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-11-12 | Janoshik | 99.88% | Not reported | Lab record ↗ |
| SER10N103025 | Sermorelin (10mg) Older lot | Paramount Peptides | 2025-11-12 | Janoshik | 99.66% | Not reported | Lab record ↗ |
| BPC10N103125 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-11-11 | Janoshik | 99.81% | Not reported | Lab record ↗ |
| S20N103025 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-11-10 | Janoshik | 99.19% | Not reported | Lab record ↗ |
| R24N102825 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-11-10 | Janoshik | 99.23% | Not reported | Lab record ↗ |
| TES20N102825 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-11-10 | Janoshik | 99.05% | Not reported | Lab record ↗ |
| EPIT10-003 | Epitalon Vial 10 mg Older lot | Peptira | 2025-11-09 | Freedom Diagnostics | 99.63% | Mass identified as Epithalon | Lab record ↗ |
| FOX10-001 | FOX04-DRI Vial 10 mg Most recent | Peptira | 2025-11-09 | Freedom Diagnostics | 99.83% | Mass identified as FOX04-DRI | Lab record ↗ |
| IPA/CJC10-004 | IPA/CJC Blend Vial 10 mg Older lot | Peptira | 2025-11-09 | Freedom Diagnostics | 99.79% | Mass identified as Ipamorelin/CJC-1295 | Lab record ↗ |
| KISS10-001 | Kisspeptin Vial 10 mg Older lot | Peptira | 2025-11-09 | Freedom Diagnostics | 99.86% | Mass identified as Kisspeptin | Lab record ↗ |
| SMAX10-005 | Semax Vial 10 mg Older lot | Peptira | 2025-11-09 | Freedom Diagnostics | 99.24% | Mass identified as Semax | Lab record ↗ |
| SERM10-004 | Sermorelin Vial 10 mg Older lot | Peptira | 2025-11-09 | Freedom Diagnostics | 99.19% | Mass identified as Sermorelin | Lab record ↗ |
| TIRZ30-006 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2025-11-09 | Freedom Diagnostics | 99.83% | Mass identified as GLP-TZ | Lab record ↗ |
| TIRZ30-005 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2025-11-09 | Freedom Diagnostics | 99.94% | Mass identified as GLP-TZ | Lab record ↗ |
| TB5A103125 | Thymosin Beta 4 (TB500) (5mg) Older lot | Paramount Peptides | 2025-11-06 | Janoshik | 99.02% | Not reported | Lab record ↗ |
| T75N102725 | GLP-2 T - 75mg Older lot | Paramount Peptides | 2025-11-05 | Janoshik | 99.81% | Not reported | Lab record ↗ |
| CNI10N102325 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-11-04 | Janoshik | Not reported | Not reported | Lab record ↗ |
| T30N102225 | GLP-2 T - 30mg Older lot | Paramount Peptides | 2025-11-04 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| CND10N102325 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2025-11-03 | Janoshik | 99.72% | Not reported | Lab record ↗ |
| GHK100N101625 | GHK-Cu (100mg) Older lot | Paramount Peptides | 2025-11-03 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| TBB20N102025 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-11-03 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TBB30N102025 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-11-03 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CAG10-004 | CAG-4 Vial 10 mg Older lot | Peptira | 2025-11-01 | Freedom Diagnostics | 99.85% | Mass identified as Cagrilintide | Lab record ↗ |
| CJCND10-003 | CJC-1295 (NoDAC) Vial 10 mg Older lot | Peptira | 2025-11-01 | Freedom Diagnostics | 99.90% | Mass identified as CJC-1295 | Lab record ↗ |
| IPA/CJC10-003 | IPA/CJC Blend Vial 10 mg Older lot | Peptira | 2025-11-01 | Freedom Diagnostics | 99.78% | Mass identified as Ipamorelin/CJC-1295 | Lab record ↗ |
| KPV10-005 | KPV Vial 10 mg Older lot | Peptira | 2025-11-01 | Freedom Diagnostics | 99.64% | Mass identified as KPV | Lab record ↗ |
| LIPOC-001 | Lipo-C Vial Most recent Discontinued | Peptira | 2025-11-01 | Freedom Diagnostics | Not reported | Mass identified as Acid (B5)/Pyridoxine | Lab record ↗ |
| MT1-10-005 | Melanotan-1 Vial 10 mg Older lot | Peptira | 2025-11-01 | Freedom Diagnostics | 99.98% | Mass identified as Melanotan I | Lab record ↗ |
| RETA30-008 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-11-01 | Freedom Diagnostics | 99.83% | Mass identified as GLP-RT | Lab record ↗ |
| TES20N102125 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-10-31 | Janoshik | 99.35% | Not reported | Lab record ↗ |
| GHK50N101625 | GHK-Cu (50mg) Older lot | Paramount Peptides | 2025-10-29 | Janoshik | 99.56% | Not reported | Lab record ↗ |
| GLO70N101425SB | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-10-29 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GLO70N101425 | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-10-29 | Janoshik | Not reported | Not reported | Lab record ↗ |
| KIS10N101425 | Kisspeptin (10mg) Older lot | Paramount Peptides | 2025-10-29 | Janoshik | 99.32% | Not reported | Lab record ↗ |
| SMX30N101525 | Semax (30mg) Older lot | Paramount Peptides | 2025-10-29 | Janoshik | 99.05% | Not reported | Lab record ↗ |
| TES10N101125 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-10-29 | Janoshik | 99.27% | Not reported | Lab record ↗ |
| S10N100925 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-10-27 | Janoshik | 99.37% | Not reported | Lab record ↗ |
| $20N101325 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-10-27 | Janoshik | 99.56% | Not reported | Lab record ↗ |
| DISP10-002 | DSIP Vial 10 mg Older lot | Peptira | 2025-10-24 | Freedom Diagnostics | 99.43% | Mass identified as DSIP | Lab record ↗ |
| RETA20-004 | RETA-3 Vial 20 mg Older lot | Peptira | 2025-10-24 | Freedom Diagnostics | 99.95% | Mass identified as GLP-RT | Lab record ↗ |
| TIRZ10-004 | TIRZ-2 Vial 10 mg Older lot | Peptira | 2025-10-24 | Freedom Diagnostics | 99.96% | Mass identified as GLP-TZ | Lab record ↗ |
| TIRZ20-005 | TIRZ-2 Vial 20 mg Older lot | Peptira | 2025-10-24 | Freedom Diagnostics | 99.96% | Mass identified as GLP-TZ | Lab record ↗ |
| TIRZ20-004 | TIRZ-2 Vial 20 mg Older lot | Peptira | 2025-10-24 | Freedom Diagnostics | 99.94% | Mass identified as GLP-TZ | Lab record ↗ |
| TIRZ60-004 | TIRZ-2 Vial 60 mg Older lot | Peptira | 2025-10-24 | Freedom Diagnostics | 99.96% | Mass identified as GLP-TZ | Lab record ↗ |
| BPC20N100925 | BPC-157 (20mg) Older lot | Paramount Peptides | 2025-10-23 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| KLOW80N101025 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-10-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| PT110N101025 | PT-141 (10mg) Older lot | Paramount Peptides | 2025-10-23 | Janoshik | 99.79% | Not reported | Lab record ↗ |
| S10N101125 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-10-22 | Janoshik | 99.30% | Not reported | Lab record ↗ |
| S10N101325 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-10-22 | Janoshik | 99.29% | Not reported | Lab record ↗ |
| S5N101125 | GLP-1 S - 5mg Most recent | Paramount Peptides | 2025-10-22 | Janoshik | 99.20% | Not reported | Lab record ↗ |
| T60N100825 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-10-22 | Janoshik | 99.79% | Not reported | Lab record ↗ |
| AOD6N100825 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-10-21 | Janoshik | 99.16% | Not reported | Lab record ↗ |
| BPC10N100225 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-10-21 | Janoshik | 99.14% | Not reported | Lab record ↗ |
| T75N100625 | GLP-2 T - 75mg Older lot | Paramount Peptides | 2025-10-21 | Janoshik | 99.48% | Not reported | Lab record ↗ |
| CUR600A100125 | Curcumin (600mg) Older lot | Paramount Peptides | 2025-10-17 | Janoshik | Not reported | Not reported | Lab record ↗ |
| T120N100725 | GLP-2 T - 120mg Older lot | Paramount Peptides | 2025-10-17 | Janoshik | 99.75% | Not reported | Lab record ↗ |
| R24N100225 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-10-17 | Janoshik | 99.89% | Not reported | Lab record ↗ |
| 25J035 | MK-677 (25mg) x 60 Tablets Most recent | Paramount Peptides | 2025-10-17 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TA110N092425 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2025-10-17 | Janoshik | 99.27% | Not reported | Lab record ↗ |
| BPC5N09225 | BPC-157 (5mg) Older lot | Paramount Peptides | 2025-10-16 | Janoshik | 99.22% | Not reported | Lab record ↗ |
| GLO50N100225 | GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-10-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 20N100125 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-10-16 | Janoshik | 99.62% | Not reported | Lab record ↗ |
| KLOW80N092625 | KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-10-13 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GHK100-001 | GHK-Cu Vial 100 mg Older lot | Peptira | 2025-10-13 | Freedom Diagnostics | 99.83% | Mass identified as GHK-Cu | Lab record ↗ |
| MT1-10-004 | Melanotan-1 Vial 10 mg Older lot | Peptira | 2025-10-13 | Freedom Diagnostics | 99.63% | Mass identified as Melanotan I | Lab record ↗ |
| MOTS40-002 | MOTS-C Vial 40 mg Older lot | Peptira | 2025-10-13 | Freedom Diagnostics | 99.63% | Mass identified as MOTS-C | Lab record ↗ |
| RETA30-007 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-10-13 | Freedom Diagnostics | 99.97% | Mass identified as Retatrutide | Lab record ↗ |
| TES10N092525 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-10-10 | Janoshik | 99.56% | Not reported | Lab record ↗ |
| 5A1M-50-001 | 5-Amino 1MQ Vial 50 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 99.78% | Mass identified as 5-Amino-1MQ | Lab record ↗ |
| BPC10-004 | BPC-157 Vial 10 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 97.74% | Mass identified as BPC-157 | Lab record ↗ |
| MOTS10-004 | MOTS-C Vial 10 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 99.72% | Mass identified as MOTS-C | Lab record ↗ |
| MOTS10-003 | MOTS-C Vial 10 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 98.85% | Mass identified as MOTS-C | Lab record ↗ |
| MOTS40-001 | MOTS-C Vial 40 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 99.73% | Mass identified as MOTS-C | Lab record ↗ |
| RETA10-004 | RETA-3 Vial 10 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 99.82% | Mass identified as Retatrutide | Lab record ↗ |
| SMAX10-004 | Semax Vial 10 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 99.41% | Mass identified as Semax | Lab record ↗ |
| WOLV10-003 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2025-10-10 | Freedom Diagnostics | 97.13% | Mass identified as TB-500/BPC-157 | Lab record ↗ |
| AOD6N092425 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.47% | Not reported | Lab record ↗ |
| S10N091925 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| S5N092225 | GLP-1 S - 5mg Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.60% | Not reported | Lab record ↗ |
| T100N092325 | GLP-2 T - 100mg Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.64% | Not reported | Lab record ↗ |
| R24N092025 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| R60N091925 | GLP-3 R - 60mg Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.57% | Not reported | Lab record ↗ |
| KPV10N091825 | KPV (10mg) Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.43% | Not reported | Lab record ↗ |
| TA110N092325 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2025-10-03 | Janoshik | 99.04% | Not reported | Lab record ↗ |
| T10N090525 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-10-02 | Janoshik | 99.69% | Not reported | Lab record ↗ |
| T10N091025 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-10-02 | Janoshik | 99.70% | Not reported | Lab record ↗ |
| T10N091225 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-10-02 | Janoshik | 99.62% | Not reported | Lab record ↗ |
| AOD6N091625 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-10-01 | Janoshik | 99.01% | Not reported | Lab record ↗ |
| TBB20N091625 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-10-01 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HEX5N091625 | Hexarelin (5mg) Older lot | Paramount Peptides | 2025-09-29 | Janoshik | 99.40% | Not reported | Lab record ↗ |
| PE210N091625 | PE-22-28 (10mg) Older lot | Paramount Peptides | 2025-09-29 | Janoshik | 99.57% | Not reported | Lab record ↗ |
| FNAD1000F091525 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-09-25 | Janoshik | Not reported | Not reported | Lab record ↗ |
| AOD6N091025 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 94.71% | Not reported | Lab record ↗ |
| CTX25N090825 | Cartalax (25mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.71% | Not reported | Lab record ↗ |
| EPI10N091125 | Epithalon (10mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.52% | Not reported | Lab record ↗ |
| EPI50A090925 | Epithalon (50mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.76% | Not reported | Lab record ↗ |
| T120N090825 | GLP-2 T - 120mg Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.89% | Not reported | Lab record ↗ |
| T60N090925 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.83% | Not reported | Lab record ↗ |
| MT210N090925 | MT-II (Melanotan II) (10mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.81% | Not reported | Lab record ↗ |
| SER15N090825 | Sermorelin (10mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| TES10N090625 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.24% | Not reported | Lab record ↗ |
| TA110N090525 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | 99.28% | Not reported | Lab record ↗ |
| TBB20N090525 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TBB20N091125 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-09-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SNAD1000N090425 | NAD+ (1000mg) Synthetic (6ml Vial) Older lot | Paramount Peptides | 2025-09-22 | Janoshik | Not reported | Not reported | Lab record ↗ |
| KPV10-004 | KPV Vial 10 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.69% | Mass identified as KPV | Lab record ↗ |
| NAD1000-001 | NAD+ Vial 1000 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.86% | Mass identified as NAD+ | Lab record ↗ |
| RETA30-006 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.45% | Mass identified as Retatrutide | Lab record ↗ |
| SEMA10-004 | SEMA-1 Vial 10 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.79% | Mass identified as Semaglutide | Lab record ↗ |
| SEMA20-004 | SEMA-1 Vial 20 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.70% | Mass identified as Semaglutide | Lab record ↗ |
| TIRZ10-003 | TIRZ-2 Vial 10 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.78% | Mass identified as Tirzepatide | Lab record ↗ |
| TIRZ30-004 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.97% | Mass identified as Tirzepatide | Lab record ↗ |
| TIRZ60-003 | TIRZ-2 Vial 60 mg Older lot | Peptira | 2025-09-19 | Freedom Diagnostics | 99.96% | Mass identified as Tirzepatide | Lab record ↗ |
| BPC10N090425 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-09-16 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| 25B005 | BPC-157 (500mcg) x 30 Tablets Most recent | Paramount Peptides | 2025-09-15 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SEMA10-003 | SEMA-1 Vial 10 mg Older lot | Peptira | 2025-09-13 | Freedom Diagnostics | 99.82% | Mass identified as Semaglutide | Lab record ↗ |
| SEMA20-003 | SEMA-1 Vial 20 mg Older lot | Peptira | 2025-09-13 | Freedom Diagnostics | 99.97% | Mass identified as Semaglutide | Lab record ↗ |
| TIRZ30-003 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2025-09-13 | Freedom Diagnostics | 99.88% | Mass identified as Tirzepatide | Lab record ↗ |
| TIRZ60-002 | TIRZ-2 Vial 60 mg Older lot | Peptira | 2025-09-13 | Freedom Diagnostics | 99.85% | Mass identified as Tirzepatide | Lab record ↗ |
| AOD6N090225 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-09-12 | Janoshik | 99.12% | Not reported | Lab record ↗ |
| R12N082525 | GLP-3 R - 10mg Older lot | Paramount Peptides | 2025-09-12 | Janoshik | 99.20% | Not reported | Lab record ↗ |
| SEL5N082725 | Selank (5mg) Older lot | Paramount Peptides | 2025-09-12 | Janoshik | 99.86% | Not reported | Lab record ↗ |
| SMX30N082825 | Semax (30mg) Older lot | Paramount Peptides | 2025-09-12 | Janoshik | 99.97% | Not reported | Lab record ↗ |
| TA1C16A090425 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2025-09-12 | Janoshik | Not reported | Not reported | Lab record ↗ |
| AOD5-002 | AOD-9604 Vial 5 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.14% | Mass identified as AOD-9604 | Lab record ↗ |
| AOD5-001 | AOD-9604 Vial 5 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.06% | Mass identified as AOD-9604 | Lab record ↗ |
| BPC10-003 | BPC-157 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.36% | Mass identified as BPC-157 | Lab record ↗ |
| CJCND10-002 | CJC-1295 (NoDAC) Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.63% | Mass identified as CJC-1295 | Lab record ↗ |
| EPIT10-002 | Epitalon Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.68% | Mass identified as Epitalon | Lab record ↗ |
| GHK50-002 | GHK-Cu Vial 50 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.01% | Mass identified as GHK-Cu | Lab record ↗ |
| GLW70-003 | GLOW Vial 70 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.33% | Mass identified as GHK-Cu/TB-500/BPC-157 | Lab record ↗ |
| GLW70-002 | GLOW Vial 70 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.61% | Mass identified as Appearance | Lab record ↗ |
| IGF1-1-002 | IGF1-LR3 Vial 1 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 98.88% | Mass identified as IGF1-LR3 | Lab record ↗ |
| IPA/CJC10-002 | IPA/CJC Blend Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.78% | Mass identified as Ipamorelin/CJC-1295 | Lab record ↗ |
| IPA10-002 | Ipamorelin Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.62% | Mass identified as Ipamorelin | Lab record ↗ |
| KLOW80-002 | KLOW Vial 80 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.49% | Mass identified as Appearance | Lab record ↗ |
| KLOW80-001 | KLOW Vial 80 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.82% | Mass identified as Appearance | Lab record ↗ |
| KPV10-003 | KPV Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.70% | Mass identified as KPV | Lab record ↗ |
| MT2-10-002 | Melanotan-2 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.44% | Mass identified as Melanotan II | Lab record ↗ |
| PT10-002 | PT-141 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.75% | Mass identified as PT-141 | Lab record ↗ |
| RETA10-003 | RETA-3 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.94% | Mass identified as Retatrutide | Lab record ↗ |
| RETA30-005 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.75% | Mass identified as Retatrutide | Lab record ↗ |
| SLNK10-002 | Selank Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.81% | Mass identified as Selank | Lab record ↗ |
| SMAX10-003 | Semax Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.61% | Mass identified as Semax | Lab record ↗ |
| SNAP10-002 | Snap-8 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.83% | Mass identified as SNAP-8 | Lab record ↗ |
| SNAP10-001 | Snap-8 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.65% | Mass identified as SNAP-8 | Lab record ↗ |
| SS10-002 | SS-31 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.87% | Mass identified as SS-31 | Lab record ↗ |
| SS50-002 | SS-31 Vial 50 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.91% | Mass identified as SS-31 | Lab record ↗ |
| WOLV10-002 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 97.56% | Mass identified as TB-500/BPC-157 | Lab record ↗ |
| TESA10-004 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.38% | Mass identified as Tesamorelin | Lab record ↗ |
| TA1-10-002 | THYMOSIN ALPHA-1 Vial 10 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.84% | Mass identified as Thymosin Alpha-1 | Lab record ↗ |
| TIRZ20-003 | TIRZ-2 Vial 20 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.82% | Mass identified as Tirzepatide | Lab record ↗ |
| TIRZ30-002 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2025-09-12 | Freedom Diagnostics | 99.96% | Mass identified as Tirzepatide | Lab record ↗ |
| BPC10N090325 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-09-11 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| IGFINO90225 | IGF-1 LR3 (1mg) Older lot | Paramount Peptides | 2025-09-11 | Janoshik | 99.92% | Not reported | Lab record ↗ |
| CJCD5-002 | CJC-1295 DAC Vial 5 mg Older lot | Peptira | 2025-09-03 | Janoshik | 99.06% | Not reported | Lab record ↗ |
| BPC10N081825 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-09-02 | Janoshik | 99.87% | Not reported | Lab record ↗ |
| CTX20N082225 | Cartalax (25mg) Older lot | Paramount Peptides | 2025-09-02 | Janoshik | 99.80% | Not reported | Lab record ↗ |
| T60N081925 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-09-02 | Janoshik | 99.93% | Not reported | Lab record ↗ |
| T60N082025 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-09-02 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| KIS5N081925 | Kisspeptin (5mg) Most recent | Paramount Peptides | 2025-09-02 | Janoshik | 99.89% | Not reported | Lab record ↗ |
| S20N082225 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-09-01 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| RETA10-002 | RETA-3 Vial 10 mg Older lot | Peptira | 2025-09-01 | Janoshik | 99.73% | Not reported | Lab record ↗ |
| RETA20-003 | RETA-3 Vial 20 mg Older lot | Peptira | 2025-09-01 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| RETA30-004 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-09-01 | Janoshik | 99.90% | Not reported | Lab record ↗ |
| CJCND10-001 | CJC-1295 (NoDAC) Vial 10 mg Older lot | Peptira | 2025-08-29 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| CJCD5-001 | CJC-1295 DAC Vial 5 mg Older lot | Peptira | 2025-08-29 | Janoshik | 99.13% | Not reported | Lab record ↗ |
| GLUT1500-001 | Glutathione Vial 1500 mg Older lot | Peptira | 2025-08-29 | Janoshik | 99.97% | Not reported | Lab record ↗ |
| NAD500-004 | NAD+ Vial 500 mg Older lot | Peptira | 2025-08-29 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TA1-10-001 | THYMOSIN ALPHA-1 Vial 10 mg Older lot | Peptira | 2025-08-29 | Janoshik | 99.33% | Not reported | Lab record ↗ |
| BPC10-002 | BPC-157 Vial 10 mg Older lot | Peptira | 2025-08-28 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| GLW70-001 | GLOW Vial 70 mg Older lot | Peptira | 2025-08-28 | Janoshik | Not reported | Not reported | Lab record ↗ |
| KPV10-002 | KPV Vial 10 mg Older lot | Peptira | 2025-08-28 | Janoshik | 99.80% | Not reported | Lab record ↗ |
| RETA30-003 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-08-28 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| SMAX10-002 | Semax Vial 10 mg Older lot | Peptira | 2025-08-28 | Janoshik | 99.44% | Not reported | Lab record ↗ |
| TIRZ20-002 | TIRZ-2 Vial 20 mg Older lot | Peptira | 2025-08-28 | Janoshik | 99.89% | Not reported | Lab record ↗ |
| 25H029 | Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 60 Tablets Most recent | Paramount Peptides | 2025-08-27 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BPC20N081425 | BPC-157 (20mg) Older lot | Paramount Peptides | 2025-08-26 | Janoshik | 99.92% | Not reported | Lab record ↗ |
| T60N081525 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-08-26 | Janoshik | 99.93% | Not reported | Lab record ↗ |
| T75N081325 | GLP-2 T - 75mg Older lot | Paramount Peptides | 2025-08-26 | Janoshik | 99.92% | Not reported | Lab record ↗ |
| PT110N081325 | PT-141 (10mg) Older lot | Paramount Peptides | 2025-08-26 | Janoshik | 99.90% | Not reported | Lab record ↗ |
| SMX30N081525 | Semax (30mg) Older lot | Paramount Peptides | 2025-08-26 | Janoshik | 99.13% | Not reported | Lab record ↗ |
| AOD6N081225 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-08-25 | Janoshik | 99.18% | Not reported | Lab record ↗ |
| IPA10A081225 | Ipamorelin (10mg) Older lot | Paramount Peptides | 2025-08-21 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| SEL10N080625 | Selank (10mg) Older lot | Paramount Peptides | 2025-08-21 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| EPI10N080625 | Epithalon (10mg) Older lot | Paramount Peptides | 2025-08-20 | Janoshik | 99.56% | Not reported | Lab record ↗ |
| FNAD1000F073025V2 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-08-20 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CND10N072625 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2025-08-19 | Janoshik | 99.35% | Not reported | Lab record ↗ |
| CDC10N080425 | CJC-1295 - With DAC (10mg) Older lot | Paramount Peptides | 2025-08-19 | Janoshik | 99.25% | Not reported | Lab record ↗ |
| TIR60N080125 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-08-19 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| KIS10N073025 | Kisspeptin (10mg) Older lot | Paramount Peptides | 2025-08-19 | Janoshik | 99.12% | Not reported | Lab record ↗ |
| TB410N072425 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2025-08-19 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| CAG10-003 | CAG-4 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.82% | Not reported | Lab record ↗ |
| CAG10-002 | CAG-4 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.49% | Not reported | Lab record ↗ |
| DSIP10-001 | DSIP Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.97% | Not reported | Lab record ↗ |
| EPIT10-001 | Epitalon Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.75% | Not reported | Lab record ↗ |
| GHK50-001 | GHK-Cu Vial 50 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.97% | Not reported | Lab record ↗ |
| IGF1-1-001 | IGF1-LR3 Vial 1 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.65% | Not reported | Lab record ↗ |
| IPA/CJC10-001 | IPA/CJC Blend Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | Not reported | Not reported | Lab record ↗ |
| MT1-10-002 | Melanotan-1 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| MOTS10-002 | MOTS-C Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.52% | Not reported | Lab record ↗ |
| NAD500-003 | NAD+ Vial 500 mg Older lot | Peptira | 2025-08-13 | Janoshik | Not reported | Not reported | Lab record ↗ |
| NAD500-002 | NAD+ Vial 500 mg Older lot | Peptira | 2025-08-13 | Janoshik | Not reported | Not reported | Lab record ↗ |
| PT10-001 | PT-141 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.94% | Not reported | Lab record ↗ |
| RETA20-002 | RETA-3 Vial 20 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.86% | Not reported | Lab record ↗ |
| RETA30-002 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.80% | Not reported | Lab record ↗ |
| SEMA10-002 | SEMA-1 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.39% | Not reported | Lab record ↗ |
| SEMA20-002 | SEMA-1 Vial 20 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.90% | Not reported | Lab record ↗ |
| SERM10-003 | Sermorelin Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.12% | Not reported | Lab record ↗ |
| SERM10-002 | Sermorelin Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.24% | Not reported | Lab record ↗ |
| SS10-001 | SS-31 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.94% | Not reported | Lab record ↗ |
| SS50-001 | SS-31 Vial 50 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| TB5-1-002 | TB-500 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.94% | Not reported | Lab record ↗ |
| WOLV10-001 | TB/BP Blend (Wolverine) Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TESA10-003 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.58% | Not reported | Lab record ↗ |
| TESA10-002 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.14% | Not reported | Lab record ↗ |
| TIRZ10-002 | TIRZ-2 Vial 10 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.91% | Not reported | Lab record ↗ |
| TIRZ60-001 | TIRZ-2 Vial 60 mg Older lot | Peptira | 2025-08-13 | Janoshik | 99.97% | Not reported | Lab record ↗ |
| 3X8N072225 | 3X Blend Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Research Blend Older lot | Paramount Peptides | 2025-08-06 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CDC10N072325 | CJC-1295 - With DAC (10mg) Older lot | Paramount Peptides | 2025-08-06 | Janoshik | 99.20% | Not reported | Lab record ↗ |
| GH25N071825 | GHRP-2 (5mg) Older lot | Paramount Peptides | 2025-08-06 | Janoshik | 99.54% | Not reported | Lab record ↗ |
| TIR60N071725 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-08-06 | Janoshik | 99.68% | Not reported | Lab record ↗ |
| 2X10N072325 | 2X Blend Tesamorelin (5mg) / Ipamorelin (5mg) Research Bundle Most recent | Paramount Peptides | 2025-08-05 | Janoshik | Not reported | Not reported | Lab record ↗ |
| MT210N072125 | MT-II (Melanotan II) (10mg) Older lot | Paramount Peptides | 2025-08-05 | Janoshik | 99.62% | Not reported | Lab record ↗ |
| SEL10N072325 | Selank (10mg) Older lot | Paramount Peptides | 2025-08-05 | Janoshik | 99.94% | Not reported | Lab record ↗ |
| P215N071625 | P21 / BDNF (Brain-derived neurotrophic factor) (10mg) Older lot | Paramount Peptides | 2025-08-03 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TES10N072225 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-08-01 | Janoshik | 99% | Not reported | Lab record ↗ |
| EPI10A072325 | Epithalon (10mg) Older lot | Paramount Peptides | 2025-07-31 | Janoshik | 99.03% | Not reported | Lab record ↗ |
| ARA16N062725 | ARA-290 (14mg) Older lot | Paramount Peptides | 2025-07-29 | Janoshik | 99.15% | Not reported | Lab record ↗ |
| EPI10N071825 | Epithalon (10mg) Older lot | Paramount Peptides | 2025-07-29 | Janoshik | 99.33% | Not reported | Lab record ↗ |
| TYG20N062725 | Thymagen (Thymogen) (20mg) Older lot | Paramount Peptides | 2025-07-29 | Janoshik | 99.86% | Not reported | Lab record ↗ |
| 2X+15N071525 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2025-07-28 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GH65N071425 | GHRP-6 (5mg) Most recent | Paramount Peptides | 2025-07-28 | Janoshik | 99.24% | Not reported | Lab record ↗ |
| RET18N070225 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-07-28 | Janoshik | 99.79% | Not reported | Lab record ↗ |
| TIR100N071625 | GLP-2 T - 100mg Older lot | Paramount Peptides | 2025-07-25 | Janoshik | 99.93% | Not reported | Lab record ↗ |
| TIR120N071525 | GLP-2 T - 120mg Older lot | Paramount Peptides | 2025-07-25 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| CNI10NO71125 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-07-22 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GHRP210N070725 | GHRP-2 (10mg) Most recent | Paramount Peptides | 2025-07-22 | Janoshik | 99.53% | Not reported | Lab record ↗ |
| TIR10N071025 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-07-22 | Janoshik | 99.25% | Not reported | Lab record ↗ |
| RET12N070725 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2025-07-22 | Janoshik | 99.33% | Not reported | Lab record ↗ |
| SER10N070925 | Sermorelin (10mg) Older lot | Paramount Peptides | 2025-07-22 | Janoshik | 99.81% | Not reported | Lab record ↗ |
| BPC5A071425 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-07-19 | Janoshik | 99.05% | Not reported | Lab record ↗ |
| KIS10A071025 | Kisspeptin (5mg) Older lot | Paramount Peptides | 2025-07-17 | Janoshik | 99.66% | Not reported | Lab record ↗ |
| TB4F10N062325 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2025-07-17 | Janoshik | 99.93% | Not reported | Lab record ↗ |
| O1DIHTESOBPC25 | Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 60 Tablets Older lot | Paramount Peptides | 2025-07-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 25A003 | Dihexa (8mg) x 30 Tablets Most recent | Paramount Peptides | 2025-07-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SEM10N070825 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-07-16 | Janoshik | 99.65% | Not reported | Lab record ↗ |
| HSEM-0015 | GLP-1 S - 5mg Older lot | Paramount Peptides | 2025-07-16 | Janoshik | 99.18% | Not reported | Lab record ↗ |
| L375N070725 | LL-37 (5mg) Most recent | Paramount Peptides | 2025-07-16 | Janoshik | 99.27% | Not reported | Lab record ↗ |
| FNAD1000F070325 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-07-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| FNAD1000F062625 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-07-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BPC10-001 | BPC-157 Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.95% | Not reported | Lab record ↗ |
| CAG10-001 | CAG-4 Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.14% | Not reported | Lab record ↗ |
| IPA10-001 | Ipamorelin Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.88% | Not reported | Lab record ↗ |
| KPV10-001 | KPV Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.41% | Not reported | Lab record ↗ |
| MT1-10-001 | Melanotan-1 Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.75% | Not reported | Lab record ↗ |
| MT2-10-001 | Melanotan-2 Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.95% | Not reported | Lab record ↗ |
| MOTS10-001 | MOTS-C Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.04% | Not reported | Lab record ↗ |
| NAD500-001 | NAD+ Vial 500 mg Older lot | Peptira | 2025-07-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| RETA20-001 | RETA-3 Vial 20 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.60% | Not reported | Lab record ↗ |
| RETA30-001 | RETA-3 Vial 30 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.93% | Not reported | Lab record ↗ |
| SLNK10-001 | Selank Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.82% | Not reported | Lab record ↗ |
| SEMA10-001 | SEMA-1 Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| SEMA20-001 | SEMA-1 Vial 20 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.93% | Not reported | Lab record ↗ |
| SEMAX10-001 | Semax Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.73% | Not reported | Lab record ↗ |
| SERM10-001 | Sermorelin Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.17% | Not reported | Lab record ↗ |
| TB5-10-001 | TB-500 Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.86% | Not reported | Lab record ↗ |
| TESA10-001 | TESAMORELIN Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.16% | Not reported | Lab record ↗ |
| TIRZ10-001 | TIRZ-2 Vial 10 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| TIRZ30-001 | TIRZ-2 Vial 30 mg Older lot | Peptira | 2025-07-16 | Janoshik | 99.82% | Not reported | Lab record ↗ |
| CNI10N062525 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-07-15 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BPC20N070125 | BPC-157 (20mg) Older lot | Paramount Peptides | 2025-07-15 | Janoshik | 99.65% | Not reported | Lab record ↗ |
| CND10N070125 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2025-07-15 | Janoshik | 99.42% | Not reported | Lab record ↗ |
| RET24N062725 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-07-15 | Janoshik | 99.57% | Not reported | Lab record ↗ |
| IPA10N062625 | Ipamorelin (10mg) Older lot | Paramount Peptides | 2025-07-15 | Janoshik | 99.97% | Not reported | Lab record ↗ |
| TBB20A062625 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-07-04 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIR50N062425 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-07-03 | Janoshik | 99.79% | Not reported | Lab record ↗ |
| 25 E 021 | 5-Amino-1mq (30mg) x 60 Tablets Older lot | Paramount Peptides | 2025-07-02 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SEM20N062425 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-07-02 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| 25 F 023 | SLU-PP-332 (250mcg) x 60 Tablets Most recent | Paramount Peptides | 2025-07-02 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SNAD1000N061825 | NAD+ (1000mg) Synthetic (6ml Vial) Older lot | Paramount Peptides | 2025-07-01 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIR60N061925 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-06-30 | Janoshik | 99.76% | Not reported | Lab record ↗ |
| FNAD1000N061825 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-06-30 | Janoshik | Not reported | Not reported | Lab record ↗ |
| AOD6N062025 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-06-29 | Janoshik | 99.28% | Not reported | Lab record ↗ |
| AODN061225 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-06-29 | Janoshik | 99.11% | Not reported | Lab record ↗ |
| BPC10A062325 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-06-29 | Janoshik | 99.17% | Not reported | Lab record ↗ |
| CAG10N061925 | Cagrilintide (10mg) Older lot | Paramount Peptides | 2025-06-29 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| SEM20N061825 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-06-29 | Janoshik | 99.64% | Not reported | Lab record ↗ |
| $3115N062025 | SS-31 (15mg) Most recent | Paramount Peptides | 2025-06-29 | Janoshik | 99.46% | Not reported | Lab record ↗ |
| TB410N062025 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2025-06-29 | Janoshik | 99.64% | Not reported | Lab record ↗ |
| RETA10-001 | RETA-3 Vial 10 mg Older lot | Peptira | 2025-06-29 | Janoshik | 99.42% | Not reported | Lab record ↗ |
| 2X+15N061825 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2025-06-26 | Janoshik | Not reported | Not reported | Lab record ↗ |
| RET12N061625 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2025-06-26 | Janoshik | 99.42% | Not reported | Lab record ↗ |
| CWD10A061725 | CJC-1295 - With DAC (10mg) Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.03% | Not reported | Lab record ↗ |
| TIR10N060925 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.75% | Not reported | Lab record ↗ |
| TIR60N061625 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.79% | Not reported | Lab record ↗ |
| PT10A061725 | PT-141 (10mg) Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.92% | Not reported | Lab record ↗ |
| SLK10A061725 | Selank (10mg) Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.86% | Not reported | Lab record ↗ |
| SER10A061725 | Sermorelin (10mg) Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.60% | Not reported | Lab record ↗ |
| TA1A061725 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.06% | Not reported | Lab record ↗ |
| TB410N061325 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2025-06-25 | Janoshik | 99.01% | Not reported | Lab record ↗ |
| TIRZ20-001 | TIRZ-2 Vial 20 mg Older lot | Peptira | 2025-06-25 | Janoshik | 99.61% | Not reported | Lab record ↗ |
| TIR75N061125 | GLP-2 T - 75mg Older lot | Paramount Peptides | 2025-06-24 | Janoshik | 99.76% | Not reported | Lab record ↗ |
| CND10A061325 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2025-06-23 | Janoshik | 99.60% | Not reported | Lab record ↗ |
| GLO42N060525 | GLOW 42 – GHK-CU (27mg) / BPC-157 (5mg) / TB500 (10mg) Most recent | Paramount Peptides | 2025-06-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIR60N061025 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-06-23 | Janoshik | 99.73% | Not reported | Lab record ↗ |
| RET12N061025 | GLP-3 R - 10mg Older lot | Paramount Peptides | 2025-06-23 | Janoshik | 99.38% | Not reported | Lab record ↗ |
| 01TESO250DIH525 | Tesofensine (250mcg) / Dihexa (5mg) x 60 Tablets Most recent | Paramount Peptides | 2025-06-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BPC10N060525 | BPC-157 (10mg) Acetylated Most recent | Paramount Peptides | 2025-06-20 | Janoshik | 99.19% | Not reported | Lab record ↗ |
| SEM20N060925 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-06-20 | Janoshik | 99.66% | Not reported | Lab record ↗ |
| RET24N060425 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-06-20 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| KPV5N060725 | KPV (5mg) Most recent | Paramount Peptides | 2025-06-20 | Janoshik | 99.70% | Not reported | Lab record ↗ |
| BPC5A061125 | BPC-157 (5mg) Older lot | Paramount Peptides | 2025-06-19 | Janoshik | 99.02% | Not reported | Lab record ↗ |
| GHK50A061025 | GHK-Cu (50mg) Older lot | Paramount Peptides | 2025-06-19 | Janoshik | 99.94% | Not reported | Lab record ↗ |
| LL375A061125 | LL-37 (5mg) Older lot | Paramount Peptides | 2025-06-19 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| MOT10A060425 | MOTs-C (10mg) Older lot | Paramount Peptides | 2025-06-12 | Janoshik | 99.60% | Not reported | Lab record ↗ |
| EPI10A060225 | Epithalon (10mg) Older lot | Paramount Peptides | 2025-06-10 | Janoshik | 99.81% | Not reported | Lab record ↗ |
| TIR75N053025 | GLP-2 T - 75mg Older lot | Paramount Peptides | 2025-06-10 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| MT210A060225 | MT-II (Melanotan II) (10mg) Older lot | Paramount Peptides | 2025-06-10 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| TB45A060225 | Thymosin Beta 4 (TB500) (5mg) Older lot | Paramount Peptides | 2025-06-10 | Janoshik | 99.07% | Not reported | Lab record ↗ |
| FNAD1000N053125 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-06-09 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SEM20N060225 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-06-08 | Janoshik | 99.51% | Not reported | Lab record ↗ |
| TIR60N053025 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-06-08 | Janoshik | 99.70% | Not reported | Lab record ↗ |
| TB410N053025 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2025-06-08 | Janoshik | 99.51% | Not reported | Lab record ↗ |
| 01BPC157250 | BPC-157 (500mcg) x 30 Tablets Older lot | Paramount Peptides | 2025-05-29 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 015AMI1Q25 | 5-Amino-1mq (15mg) x 60 Tablets Most recent | Paramount Peptides | 2025-05-28 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 01SLU1MG25 | SLU-PP-332 (1mg) x 60 Tablets Older lot | Paramount Peptides | 2025-05-28 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 25D014 | SLU-PP-332 (250mcg) x 60 Tablets Older lot | Paramount Peptides | 2025-05-28 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HSEM-0018 | GLP-1 S - 5mg Older lot | Paramount Peptides | 2025-05-27 | Janoshik | 99.39% | Not reported | Lab record ↗ |
| CNI10N051325 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-05-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SEM20N051225 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-05-23 | Janoshik | 99.44% | Not reported | Lab record ↗ |
| TIR60N051225 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-05-23 | Janoshik | 99.69% | Not reported | Lab record ↗ |
| TBB20N050725 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-05-23 | Janoshik | Not reported | Not reported | Lab record ↗ |
| FNAD1000F051425 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-05-21 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CTX20N050825 | Cartalax (25mg) Older lot | Paramount Peptides | 2025-05-18 | Janoshik | 99.25% | Not reported | Lab record ↗ |
| SEM20N050825 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-05-18 | Janoshik | 99.69% | Not reported | Lab record ↗ |
| BDN10073124 | P21 / BDNF (Brain-derived neurotrophic factor) (10mg) Older lot | Paramount Peptides | 2025-05-16 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIR10N050125 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-05-14 | Janoshik | 99.19% | Not reported | Lab record ↗ |
| IPA10N050525 | Ipamorelin (10mg) Older lot | Paramount Peptides | 2025-05-14 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| TA110050125 | Thymosin Alpha 1 (TA1) (10mg) Older lot | Paramount Peptides | 2025-05-14 | Janoshik | 99.48% | Not reported | Lab record ↗ |
| CUR042325 | Curcumin (600mg) Older lot | Paramount Peptides | 2025-05-11 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CNI10n042425 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-05-07 | Janoshik | Not reported | Not reported | Lab record ↗ |
| RET24n042825 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-05-07 | Janoshik | 99.44% | Not reported | Lab record ↗ |
| MT210n042525 | MT-II (Melanotan II) (10mg) Older lot | Paramount Peptides | 2025-05-07 | Janoshik | 99.41% | Not reported | Lab record ↗ |
| SEM5C102024 | GLP-1 S - 5mg Older lot | Paramount Peptides | 2025-05-05 | Janoshik | 99.56% | Not reported | Lab record ↗ |
| TB45C€20125 | Thymosin Beta 4 (TB500) (5mg) Older lot | Paramount Peptides | 2025-05-05 | Janoshik | 99.03% | Not reported | Lab record ↗ |
| FNAD1000F041825 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-05-02 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIR60N042225 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-04-30 | Janoshik | 99.42% | Not reported | Lab record ↗ |
| PT15n041725 | PT-141 (5mg) Most recent | Paramount Peptides | 2025-04-30 | Janoshik | 99.27% | Not reported | Lab record ↗ |
| TES10N042325Z | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-04-30 | Janoshik | 99.61% | Not reported | Lab record ↗ |
| TES10N042325 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-04-30 | Janoshik | 99.61% | Not reported | Lab record ↗ |
| AOD3n042125v2 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.24% | Not reported | Lab record ↗ |
| AO0D3n042125 | AOD 9604 (6mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.21% | Not reported | Lab record ↗ |
| CRD20N041525 | Cardiogen (20mg) Most recent | Paramount Peptides | 2025-04-29 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| GHK100N041025 | GHK-Cu (100mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.92% | Not reported | Lab record ↗ |
| IGF1042325 | IGF-1 LR3 (1mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.23% | Not reported | Lab record ↗ |
| MOT10042325 | MOTs-C (10mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.01% | Not reported | Lab record ↗ |
| MOT10N041525 | MOTs-C (10mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.30% | Not reported | Lab record ↗ |
| MT2042325 | MT-II (Melanotan II) (10mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.42% | Not reported | Lab record ↗ |
| TES10N041525 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2025-04-29 | Janoshik | 99.30% | Not reported | Lab record ↗ |
| BPC20N040725 | BPC-157 (20mg) Older lot | Paramount Peptides | 2025-04-18 | Janoshik | 99.33% | Not reported | Lab record ↗ |
| TBB20N040825 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-04-18 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BPC10N040125 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-04-10 | Janoshik | 99.38% | Not reported | Lab record ↗ |
| FNAD1000F032825 | NAD+ (1000mg) Biofermented (5ml Vial) Older lot | Paramount Peptides | 2025-04-09 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GHK75n032425 | GHK-Cu (50mg) Older lot | Paramount Peptides | 2025-04-03 | Janoshik | 99.94% | Not reported | Lab record ↗ |
| GH-0002 | GHRP-2 (10mg) Older lot | Paramount Peptides | 2025-04-03 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| SEM10N032525 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-04-03 | Janoshik | 99.09% | Not reported | Lab record ↗ |
| PT141-0003 | PT-141 (10mg) Older lot | Paramount Peptides | 2025-04-03 | Janoshik | 99.80% | Not reported | Lab record ↗ |
| NAD750A032025 | NAD+ (1000mg) Older lot | Paramount Peptides | 2025-03-28 | Janoshik | Not reported | Not reported | Lab record ↗ |
| SER10N031925 | Sermorelin (10mg) Older lot | Paramount Peptides | 2025-03-28 | Janoshik | 99.50% | Not reported | Lab record ↗ |
| CNI10N031225 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-03-20 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TBB20N031125 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-03-20 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIR60N030425 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2025-03-18 | Janoshik | 99.84% | Not reported | Lab record ↗ |
| NAD1000N022025 | NAD+ (1000mg) Older lot | Paramount Peptides | 2025-03-07 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 2XN021925 | 2X Blend Tesamorelin (5mg) / Ipamorelin (5mg) Research Bundle Older lot | Paramount Peptides | 2025-03-06 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BPC20N021725 | BPC-157 (20mg) Older lot | Paramount Peptides | 2025-03-06 | Janoshik | 99.59% | Not reported | Lab record ↗ |
| TIR10N022125 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-03-06 | Janoshik | 99.50% | Not reported | Lab record ↗ |
| TIR30N022525 | GLP-2 T - 30mg Older lot | Paramount Peptides | 2025-03-06 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| SER10N022025 | Sermorelin (10mg) Older lot | Paramount Peptides | 2025-03-06 | Janoshik | 99.46% | Not reported | Lab record ↗ |
| BPC10N020725 | BPC-157 (10mg) Older lot | Paramount Peptides | 2025-02-20 | Janoshik | 99.73% | Not reported | Lab record ↗ |
| CAG10N020525 | Cagrilintide (10mg) Older lot | Paramount Peptides | 2025-02-20 | Janoshik | 99.71% | Not reported | Lab record ↗ |
| RET12N021125 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2025-02-20 | Janoshik | 99.72% | Not reported | Lab record ↗ |
| CNI10 NO13025 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2025-02-14 | Janoshik | Not reported | Not reported | Lab record ↗ |
| 2x+15n020325 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2025-02-14 | Janoshik | Not reported | Not reported | Lab record ↗ |
| RET24N012925 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2025-02-14 | Janoshik | 99.62% | Not reported | Lab record ↗ |
| SER10N020325 | Sermorelin (10mg) Older lot | Paramount Peptides | 2025-02-14 | Janoshik | 99.25% | Not reported | Lab record ↗ |
| TBB20N012725 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-02-14 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIR10N011625 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-01-31 | Janoshik | 99.36% | Not reported | Lab record ↗ |
| TIR10N011525 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2025-01-31 | Janoshik | 99.36% | Not reported | Lab record ↗ |
| TIR30N011725 | GLP-2 T - 30mg Older lot | Paramount Peptides | 2025-01-31 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| TIR30N012025 | GLP-2 T - 30mg Older lot | Paramount Peptides | 2025-01-31 | Janoshik | 99.64% | Not reported | Lab record ↗ |
| SEM20N010625 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-01-18 | Janoshik | 99.78% | Not reported | Lab record ↗ |
| SEM20N01022025 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2025-01-18 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| SEM10N12232024 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-01-09 | Janoshik | 99.61% | Not reported | Lab record ↗ |
| SEM10N12302024 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-01-09 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| GHK50N12182024 | GHK-Cu (50mg) Older lot | Paramount Peptides | 2025-01-02 | Janoshik | 99.94% | Not reported | Lab record ↗ |
| SEM10N12172024 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2025-01-02 | Janoshik | 99.74% | Not reported | Lab record ↗ |
| SUR6N12192024 | Survodutide (6mg) Most recent | Paramount Peptides | 2025-01-02 | Janoshik | 99.47% | Not reported | Lab record ↗ |
| TB410N12162024 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2025-01-02 | Janoshik | 99.37% | Not reported | Lab record ↗ |
| TBB20N12172024 | Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2025-01-02 | Janoshik | Not reported | Not reported | Lab record ↗ |
| TIRRAW-0068 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-12-23 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| TIRRAW-0069 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-12-23 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| BPC10N12122024 | BPC-157 (10mg) Older lot | Paramount Peptides | 2024-12-21 | Janoshik | 99.57% | Not reported | Lab record ↗ |
| RET10N12112024 | GLP-3 R - 10mg Older lot | Paramount Peptides | 2024-12-21 | Janoshik | 99.18% | Not reported | Lab record ↗ |
| TES10N12102024 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2024-12-21 | Janoshik | 99.43% | Not reported | Lab record ↗ |
| DV-0005-77 | BPC-157 (500mcg) x 30 Tablets Older lot | Paramount Peptides | 2024-12-18 | Janoshik | Not reported | Not reported | Lab record ↗ |
| CNI10N11272024 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2024-12-17 | Janoshik | Not reported | Not reported | Lab record ↗ |
| BPC10N11252024 | BPC-157 (10mg) Older lot | Paramount Peptides | 2024-12-17 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| TES10N11252024 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2024-12-17 | Janoshik | 99.34% | Not reported | Lab record ↗ |
| SEM10N12032024 | GLP-1 S - 10mg Older lot | Paramount Peptides | 2024-12-15 | Janoshik | 99.55% | Not reported | Lab record ↗ |
| TIR10N12022024 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-12-15 | Janoshik | 99.36% | Not reported | Lab record ↗ |
| TIRRAW-0064 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-12-15 | Janoshik | 99.70% | Not reported | Lab record ↗ |
| TIRRAW-0066 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-12-15 | Janoshik | 99.21% | Not reported | Lab record ↗ |
| TIRRAW-0067 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-12-15 | Janoshik | 99.52% | Not reported | Lab record ↗ |
| TIRRAW-0062 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-12-15 | Janoshik | 99.63% | Not reported | Lab record ↗ |
| TIRRAW-0061 | GLP-2 T - 20mg Most recent | Paramount Peptides | 2024-12-15 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| BPC20N12042024 | BPC-157 (20mg) Older lot | Paramount Peptides | 2024-12-14 | Janoshik | 99.52% | Not reported | Lab record ↗ |
| SEM2N12032024 | GLP-1 S - 2mg Most recent | Paramount Peptides | 2024-12-14 | Janoshik | 99.36% | Not reported | Lab record ↗ |
| 2XN11192024 | 2X Blend Tesamorelin (5mg) / Ipamorelin (5mg) Research Bundle Older lot | Paramount Peptides | 2024-12-04 | Janoshik | Not reported | Not reported | Lab record ↗ |
| RET24N11182024 | GLP-3 R - 24mg Older lot | Paramount Peptides | 2024-12-04 | Janoshik | 99.67% | Not reported | Lab record ↗ |
| IPA10N11182024 | Ipamorelin (10mg) Older lot | Paramount Peptides | 2024-12-04 | Janoshik | 99.63% | Not reported | Lab record ↗ |
| MOT10N11202024 | MOTs-C (10mg) Older lot | Paramount Peptides | 2024-12-04 | Janoshik | 99.42% | Not reported | Lab record ↗ |
| MK-677 | MK-677 (25mg) x 60 Tablets Older lot | Paramount Peptides | 2024-12-02 | Janoshik | Not reported | Not reported | Lab record ↗ |
| GHK100N11132024 | GHK-Cu (50mg) Older lot | Paramount Peptides | 2024-11-22 | Janoshik | 99.90% | Not reported | Lab record ↗ |
| TIR60N11112024 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2024-11-22 | Janoshik | 99.66% | Not reported | Lab record ↗ |
| RET12N11142024 | GLP-3 R - 12mg Older lot | Paramount Peptides | 2024-11-22 | Janoshik | 99.52% | Not reported | Lab record ↗ |
| SER10N11122024 | Sermorelin (10mg) Older lot | Paramount Peptides | 2024-11-22 | Janoshik | 99.33% | Not reported | Lab record ↗ |
| TES10N11142024 | Tesamorelin (10mg) Older lot | Paramount Peptides | 2024-11-22 | Janoshik | 99.58% | Not reported | Lab record ↗ |
| BPC10N11062024 | BPC-157 (10mg) Older lot | Paramount Peptides | 2024-11-15 | Janoshik | 99.46% | Not reported | Lab record ↗ |
| NDAC10N11042024 | CJC-1295 - No DAC (10mg) Older lot | Paramount Peptides | 2024-11-15 | Janoshik | 99.01% | Not reported | Lab record ↗ |
| SEM2.5N11042024 | GLP-1 S - 2mg Older lot | Paramount Peptides | 2024-11-15 | Janoshik | 99.68% | Not reported | Lab record ↗ |
| TIR30N11052024 | GLP-2 T - 30mg Older lot | Paramount Peptides | 2024-11-15 | Janoshik | 99.77% | Not reported | Lab record ↗ |
| HNIB-0001 | 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Older lot | Paramount Peptides | 2024-11-07 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HHEX-0001 | Hexarelin (5mg) Older lot | Paramount Peptides | 2024-11-07 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HSLK-0002 | Selank (5mg) Older lot | Paramount Peptides | 2024-11-07 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HTB4-0005 | Thymosin Beta 4 (TB500) (10mg) Older lot | Paramount Peptides | 2024-11-07 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HTIB-0004 | 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend Older lot | Paramount Peptides | 2024-11-05 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HDSIP-0003 | DSIP (5mg) Older lot | Paramount Peptides | 2024-10-28 | Janoshik | 99.87% | Not reported | Lab record ↗ |
| HBPC-0005 | BPC-157 (10mg) Older lot | Paramount Peptides | 2024-10-09 | Janoshik | 99.10% | Not reported | Lab record ↗ |
| HSEM-0019 | GLP-1 S - 20mg Older lot | Paramount Peptides | 2024-09-27 | Janoshik | 99.71% | Not reported | Lab record ↗ |
| HTIR-0048 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2024-09-27 | Janoshik | 99.85% | Not reported | Lab record ↗ |
| HTIR-0047 | GLP-2 T - 60mg Older lot | Paramount Peptides | 2024-09-25 | Janoshik | 99.81% | Not reported | Lab record ↗ |
| WTIR-0005 | GLP-2 T - 10mg Older lot | Paramount Peptides | 2024-09-24 | Janoshik | 99.54% | Not reported | Lab record ↗ |
| GLO-0001 | GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) Older lot | Paramount Peptides | 2024-09-19 | Janoshik | Not reported | Not reported | Lab record ↗ |
| HSEM-0017 | GLP-1 S - 2mg Older lot | Paramount Peptides | 2024-09-19 | Janoshik | 99.52% | Not reported | Lab record ↗ |
| HCAG-0006 | Cagrilintide (10mg) Older lot | Paramount Peptides | 2024-09-17 | Janoshik | 99.27% | Not reported | Lab record ↗ |
| SSER-0001 | Sermorelin (10mg) Older lot | Paramount Peptides | 2024-09-17 | Janoshik | 99.43% | Not reported | Lab record ↗ |
Shop the vendors behind these COAs
Paramount Peptides
565 lots on file · labs: Accumark Labs, Janoshik
Shop Paramount Peptides ↗Use code SKYLER for 10% off
Peptira
325 lots on file · labs: Freedom Diagnostics, Janoshik
Shop Peptira ↗Use code SKYLER for 10% off
Affiliate links. We earn a commission if you buy through the vendor links on this page, at no extra cost to you. Peptides & Coffee is an independent COA reference and is not owned by or affiliated with the vendors or labs listed. Lab results are published by the vendors and labs; we link to each lab's own verification record so you can check them yourself.
Latest COA for each product
- 2X Blend CJC-1295 No DAC (5mg) / Ipamorelin (5mg) (Paramount Peptides, 2026-08-12)
- 2X Blend Tesamorelin (10mg) / Ipamorelin (2mg) Research Blend (Paramount Peptides, 2026-07-17)
- 2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) Research Blend (Paramount Peptides, 2026-08-21)
- 2X Blend Tesamorelin (5mg) / Ipamorelin (5mg) Research Bundle (Paramount Peptides, 2025-08-05)
- 3X Blend Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Research Blend (Paramount Peptides, 2026-06-26)
- 4X Blend GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) (Paramount Peptides, 2026-03-13)
- 5-Amino 1MQ Caps 50 mg 60ct (Peptira, 2026-03-03)
- 5-Amino 1MQ Tablets 50 mg 60ct (Peptira, 2026-09-19)
- 5-Amino 1MQ Vial 50 mg (Peptira, 2026-06-15)
- 5-Amino-1mq (15mg) x 60 Tablets (Paramount Peptides, 2025-05-28)
- 5-Amino-1mq (30mg) x 60 Tablets (Paramount Peptides, 2025-12-03)
- 5-Amino-1mq (50mg) x 60 Tablets (Paramount Peptides, 2026-06-02)
- Adamax Vial 10 mg (Peptira, 2026-08-29)
- AHK-Cu Raw 1 g (Peptira, 2026-06-15)
- Aicar Vial 50 mg (Peptira, 2026-02-10)
- AOD 9604 (6mg) (Paramount Peptides, 2026-04-17)
- AOD-9604 Vial 5 mg (Peptira, 2026-04-12)
- ARA-290 (14mg) (Paramount Peptides, 2025-11-27)
- ARA-290 Vial 10 mg (Peptira, 2026-01-31)
- ARA-290 Vial 30 mg (Peptira, 2026-09-14)
- ATX-304 (100mg) x 60 Tablets (Paramount Peptides, 2026-02-10)
- BAM15 Caps 50 mg 60ct (Peptira, 2026-03-05)
- BPC-157 (10mg) (Paramount Peptides, 2026-07-07)
- BPC-157 (10mg) Acetylated (Paramount Peptides, 2025-06-20)
- BPC-157 (1mg) x 60 Tablets (Paramount Peptides, 2026-04-17)
- BPC-157 (20mg) (Paramount Peptides, 2026-07-20)
- BPC-157 (500mcg) x 30 Tablets (Paramount Peptides, 2025-09-15)
- BPC-157 (5mg) (Paramount Peptides, 2026-07-06)
- BPC-157 Caps 500 mg 60ct (Peptira, 2025-12-06)
- BPC-157 Tablets 0.5 mg 60ct (Peptira, 2026-09-19)
- BPC-157 Vial 10 mg (Peptira, 2026-08-04)
- BPC/KPV Caps 1 mg 60ct (Peptira, 2026-01-18)
- CAG-4 Vial 10 mg (Peptira, 2026-07-28)
- Cagrilintide (10mg) (Paramount Peptides, 2026-06-26)
- Cardiogen (20mg) (Paramount Peptides, 2025-04-29)
- Cartalax (25mg) (Paramount Peptides, 2026-04-22)
- Cartalax Vial 20 mg (Peptira, 2026-08-22)
- CJC-1295 (NoDAC) Vial 10 mg (Peptira, 2025-12-26)
- CJC-1295 - No DAC (10mg) (Paramount Peptides, 2026-07-22)
- CJC-1295 - With DAC (10mg) (Paramount Peptides, 2026-07-02)
- CJC-1295 DAC Vial 5 mg (Peptira, 2026-01-31)
- Cortagen Vial 20 mg (Peptira, 2026-05-28)
- Curcumin (600mg) (Paramount Peptides, 2026-03-16)
- Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 60 Tablets (Paramount Peptides, 2025-08-27)
- Dihexa (10mg) x 30 Tablets (Paramount Peptides, 2025-12-03)
- Dihexa (8mg) x 30 Tablets (Paramount Peptides, 2025-07-16)
- DSIP (10mg) (Paramount Peptides, 2026-08-21)
- DSIP (5mg) (Paramount Peptides, 2026-07-06)
- DSIP Vial 10 mg (Peptira, 2025-12-23)
- Epitalon Tablets 3 mg 60ct (Peptira, 2026-09-19)
- Epitalon Vial 10 mg (Peptira, 2026-08-04)
- Epithalon (10mg) (Paramount Peptides, 2026-07-07)
- Epithalon (50mg) (Paramount Peptides, 2026-08-11)
- Fenbendazole (200mg) x 30 Tablets (Paramount Peptides, 2026-02-11)
- FOX04-DRI Vial 10 mg (Peptira, 2025-11-09)
- FOXO4-DRI (15mg) (Paramount Peptides, 2026-04-17)
- GHK-Cu (100mg) (Paramount Peptides, 2026-07-06)
- GHK-Cu (50mg) (Paramount Peptides, 2026-06-26)
- GHK-Cu Caps 2 mg 60ct (Peptira, 2026-01-31)
- GHK-Cu Raw 1 g (Peptira, 2026-02-21)
- GHK-Cu Tablets 2 mg 60ct (Peptira, 2026-09-19)
- GHK-Cu Vial 100 mg (Peptira, 2026-03-05)
- GHK-Cu Vial 50 mg (Peptira, 2026-03-05)
- GHRP-2 (10mg) (Paramount Peptides, 2025-07-22)
- GHRP-2 (5mg) (Paramount Peptides, 2026-04-16)
- GHRP-6 (5mg) (Paramount Peptides, 2025-07-28)
- GHRP-6 Vial 5 mg (Peptira, 2026-01-11)
- GLOW 42 – GHK-CU (27mg) / BPC-157 (5mg) / TB500 (10mg) (Paramount Peptides, 2025-06-23)
- GLOW 50 GHK-CU (30mg) / BPC-157 (10mg) / TB500 (10mg) (Paramount Peptides, 2026-07-06)
- GLOW 70 GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg) (Paramount Peptides, 2026-08-21)
- GLOW Vial 70 mg (Peptira, 2025-12-06)
- GLP-1 S - 10mg (Paramount Peptides, 2025-11-25)
- GLP-1 S - 20mg (Paramount Peptides, 2026-04-14)
- GLP-1 S - 2mg (Paramount Peptides, 2024-12-14)
- GLP-1 S - 50mg (Paramount Peptides, 2026-03-05)
- GLP-1 S - 5mg (Paramount Peptides, 2025-10-22)
- GLP-2 T - 100mg (Paramount Peptides, 2026-08-04)
- GLP-2 T - 10mg (Paramount Peptides, 2026-07-01)
- GLP-2 T - 120mg (Paramount Peptides, 2026-02-02)
- GLP-2 T - 20mg (Paramount Peptides, 2024-12-15)
- GLP-2 T - 30mg (Paramount Peptides, 2026-04-18)
- GLP-2 T - 40mg (Paramount Peptides, 2025-11-28)
- GLP-2 T - 60mg (Paramount Peptides, 2026-06-28)
- GLP-2 T - 75mg (Paramount Peptides, 2026-06-23)
- GLP-3 R - 10mg (Paramount Peptides, 2026-02-09)
- GLP-3 R - 12mg (Paramount Peptides, 2026-07-07)
- GLP-3 R - 24mg (Paramount Peptides, 2026-04-14)
- GLP-3 R - 60mg (Paramount Peptides, 2026-06-18)
- Glutathione Vial 1500 mg (Peptira, 2026-08-04)
- Gonadorelin (10mg) (Paramount Peptides, 2025-12-30)
- Gonadorelin (5mg) (Paramount Peptides, 2026-04-16)
- Hexarelin (5mg) (Paramount Peptides, 2026-03-18)
- HSN BLEND Liquid 20 ml (Peptira, 2026-09-05)
- IGF-1 LR3 (1mg) (Paramount Peptides, 2026-07-06)
- IGF1-LR3 Vial 1 mg (Peptira, 2026-03-19)
- IPA/CJC Blend Vial 10 mg (Peptira, 2026-04-16)
- Ipamorelin (10mg) (Paramount Peptides, 2026-08-21)
- Ipamorelin Vial 10 mg (Peptira, 2026-05-01)
- Kisspeptin (10mg) (Paramount Peptides, 2026-03-06)
- Kisspeptin (5mg) (Paramount Peptides, 2025-09-02)
- Kisspeptin Vial 10 mg (Peptira, 2026-02-10)
- KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg) (Paramount Peptides, 2026-07-06)
- KLOW Vial 80 mg (Peptira, 2026-02-10)
- KPV (10mg) (Paramount Peptides, 2026-07-02)
- KPV (5mg) (Paramount Peptides, 2025-06-20)
- KPV Tablets 0.5 mg 60ct (Peptira, 2026-09-19)
- KPV Vial 10 mg (Peptira, 2026-08-06)
- KPV/TB/BPC (Phoenix) Vial 30 mg (Peptira, 2026-01-01)
- L-CARNITINE Liquid 10 ml (Peptira, 2026-04-15)
- L-CARNITINE Liquid 20 ml (Peptira, 2025-11-20)
- Lipo-C Vial (Peptira, 2025-11-01)
- Lipo-C XL Liquid 20 ml (Peptira, 2026-08-22)
- LL-37 (5mg) (Paramount Peptides, 2025-07-16)
- LL-37 Vial 5 mg (Peptira, 2026-01-31)
- Melanotan-1 Vial 10 mg (Peptira, 2026-05-01)
- Melanotan-2 Vial 10 mg (Peptira, 2026-01-01)
- Methylene Blue Tablets 20 mg 60ct (Peptira, 2026-09-26)
- MK-677 (25mg) x 60 Tablets (Paramount Peptides, 2025-10-17)
- MOTs-C (10mg) (Paramount Peptides, 2026-06-26)
- MOTS-C Vial 10 mg (Peptira, 2026-06-15)
- MOTS-C Vial 40 mg (Peptira, 2026-05-28)
- MT-II (Melanotan II) (10mg) (Paramount Peptides, 2026-07-06)
- NAD+ (1000mg) (Paramount Peptides, 2026-06-26)
- NAD+ (1000mg) Biofermented (5ml Vial) (Paramount Peptides, 2026-06-04)
- NAD+ (1000mg) Synthetic (6ml Vial) (Paramount Peptides, 2026-04-16)
- NAD+ Vial 1000 mg (Peptira, 2026-06-15)
- NAD+ Vial 500 mg (Peptira, 2026-03-19)
- Orforglipron (12mg) x 60 Tablets (Paramount Peptides, 2025-12-18)
- Orforglipron (6mg) x 60 Tablets (Paramount Peptides, 2025-12-18)
- Oxytocin (10mg) (Paramount Peptides, 2026-07-07)
- Oxytocin Vial 2 mg (Peptira, 2026-01-01)
- P21 / BDNF (Brain-derived neurotrophic factor) (10mg) (Paramount Peptides, 2025-11-29)
- PE-22-28 (10mg) (Paramount Peptides, 2026-04-17)
- PE-22-28 Vial 10 mg (Peptira, 2026-08-22)
- PEEL'd Liquid 20 ml (Peptira, 2026-07-03)
- PEG MGF (5mg) (Paramount Peptides, 2026-03-16)
- Pinealon Tablets 3 mg 60ct (Peptira, 2026-09-19)
- Pinealon Vial 10 mg (Peptira, 2025-11-20)
- PT-141 (10mg) (Paramount Peptides, 2026-02-02)
- PT-141 (5mg) (Paramount Peptides, 2025-04-30)
- PT-141 Vial 10 mg (Peptira, 2026-01-01)
- Pumptira Liquid 20 ml (Peptira, 2026-03-19)
- RETA-3 Vial 10 mg (Peptira, 2026-08-04)
- RETA-3 Vial 20 mg (Peptira, 2026-08-04)
- RETA-3 Vial 30 mg (Peptira, 2026-08-29)
- Selank (10mg) (Paramount Peptides, 2026-07-06)
- Selank (5mg) (Paramount Peptides, 2026-07-06)
- Selank Vial 10 mg (Peptira, 2026-01-01)
- SEMA-1 Vial 10 mg (Peptira, 2026-04-12)
- SEMA-1 Vial 20 mg (Peptira, 2026-01-01)
- Semax (30mg) (Paramount Peptides, 2026-04-16)
- Semax Vial 10 mg (Peptira, 2026-08-04)
- Sermorelin (10mg) (Paramount Peptides, 2025-12-02)
- Sermorelin Vial 10 mg (Peptira, 2026-01-11)
- SLU-PP-332 (1mg) x 60 Tablets (Paramount Peptides, 2026-02-06)
- SLU-PP-332 (250mcg) x 60 Tablets (Paramount Peptides, 2025-07-02)
- SLU-PP-332 Caps 500 mg 60ct (Peptira, 2026-01-31)
- SLU-PP-332 Tablets 100 mg 60ct (Peptira, 2026-09-26)
- SLU/BAM15 Caps 1 mg 60ct (Peptira, 2026-01-31)
- Snap-8 Vial 10 mg (Peptira, 2026-04-02)
- SS-31 (14mg) (Paramount Peptides, 2026-03-18)
- SS-31 (15mg) (Paramount Peptides, 2025-06-29)
- SS-31 Vial 10 mg (Peptira, 2026-04-12)
- SS-31 Vial 50 mg (Peptira, 2026-07-03)
- Survo Vial 10 mg (Peptira, 2026-01-31)
- Survodutide (6mg) (Paramount Peptides, 2025-01-02)
- TB-500 Vial 10 mg (Peptira, 2026-04-16)
- TB/BP Blend (Wolverine) Vial 10 mg (Peptira, 2026-08-04)
- Tesamorelin (10mg) (Paramount Peptides, 2026-06-01)
- TESAMORELIN Vial 10 mg (Peptira, 2026-08-22)
- TESAMORELIN Vial 30 mg (Peptira, 2026-08-22)
- Tesofensine (250mcg) / Dihexa (5mg) x 60 Tablets (Paramount Peptides, 2025-06-23)
- Tesofensine Caps 500 mg 60ct (Peptira, 2025-12-06)
- Thymagen (Thymogen) (20mg) (Paramount Peptides, 2026-02-24)
- Thymagen Vial 20 mg (Peptira, 2026-05-28)
- Thymalin (20mg) (Paramount Peptides, 2026-03-17)
- Thymalin Vial 10 mg (Peptira, 2026-02-10)
- Thymosin Alpha 1 (TA1) (10mg) (Paramount Peptides, 2026-06-28)
- Thymosin Alpha 1 (Tα1) Vial 5 mg (Peptira, 2026-01-11)
- THYMOSIN ALPHA-1 Vial 10 mg (Peptira, 2026-08-11)
- Thymosin Beta 4 (TB500) (10mg) (Paramount Peptides, 2026-07-08)
- Thymosin Beta 4 (TB500) (20mg) (Paramount Peptides, 2026-05-15)
- Thymosin Beta 4 (TB500) (5mg) (Paramount Peptides, 2026-04-17)
- TIRZ-2 Vial 10 mg (Peptira, 2026-04-02)
- TIRZ-2 Vial 20 mg (Peptira, 2026-04-02)
- TIRZ-2 Vial 30 mg (Peptira, 2026-04-15)
- TIRZ-2 Vial 60 mg (Peptira, 2026-08-04)
- Triple Regulator (TIA-39-C20) (12mg) (Paramount Peptides, 2026-08-21)
- Vilon Vial 20 mg (Peptira, 2026-05-01)
- VIP Vial 10 mg (Peptira, 2025-11-20)
- Wolverine Blend - BPC-157 (10mg) / TB500 (10mg) (Paramount Peptides, 2026-09-22)
- Wolverine Blend - BPC-157 (5mg) / TB500 (5mg) (Paramount Peptides, 2026-05-18)
Our COA testing and listing policy
We don't test products ourselves and we don't edit lab results. For each lot we list, we record what the testing laboratory reported and link to that lab's own verification record so you can check it independently.
- Lot-level only. Every page is tied to one lot or batch number. A COA for one lot says nothing about a different lot, so match the number on your vial label.
- Lab-verifiable. Where the lab offers a public lookup (for example Accumark Labs' AccuVerify page or Freedom Diagnostics' COA lookup), we link straight to it and note whether the lab's record matched the lot when we last checked.
- What we show. HPLC purity (the share of UV-detected material that is the main peptide peak), the identity result and the method the lab used (for example LC-MS or HPLC retention time), test date, and any extra tests on the report such as endotoxin, heavy metals or microbial screening.
- Gaps are shown, not filled. If a COA doesn't report something (for example, an amount-only test with no purity), the page says so. We never estimate missing values.
- Updates. The newest COA for each product is marked "Most recent COA". Older lots stay online so anyone holding an older vial can still check it.
Want to understand what you're looking at? Read How to read a peptide COA: HPLC purity, mass spec identity, lot numbers, lab accreditation and the red flags of a fake COA.